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The aim of this study is to investigate the phytochemical compounds present in standard COA®, 
dichloromethane (DCM), ethanol (EtOH), hexane (HEX), and ethyl acetate (EtOAc) , extracts of 
COA® compared to leaf extracts of Vernonia  amygdalina and Persea americana collected from 
Cape Coast (Ghana) and Durban (South Africa) by phytochemical screening techniques and gas 
chromatography-mass spectrometry (GC-MS) analysis.  
Findings from this study revealed that leaf extracts of   P. americana and V. amygdalina have 
been used in many local African communities for management of various diseases. 
Ethnomedicinal use and pharmacological properties of leaf extracts of P. americana andV. 
amygdalina may justify polyherbal formulation involving the two plants in the treatment of 
diseases such as diabetes, hypertension and other diseases.   
 Outcomes of the preliminary phytochemicals screening showed the presence of alkaloids, 
anthraquinones, saponins, flavonoids, tannins, terpenoids and glucosides in ethanolic leaf extracts 
and standard COA®.   
GC-MS study of standard COA®, COA® extract and leaf extracts of P. americana and V. 
amygdalina collected from Ghana and South Africa had 60y phytochemical compounds identified 
in the hexane extract of COA® extract, 47 in DCM, 37 in ethyl acetate, 18in ethanol and 11 in 
standard COA® herbal medicine. The identification of phytochemical compounds and 
pharmacological actions was based on the name of the chemical compound, retention time and 
molecular formula from GC-MS analysis. The major phytochemicals common to COA® extract 
and leaf extracts of P. americana and V. amygdalina were heneicosane, phytyl acetate, pyrene, 
octadecanoic acid, eicosane, 2-methyltetracosane, pentadecanoic acid, hexadecanamide, and 
octadecanamide. Most of these major phytochemicals are present in ethanolic extracts of both 
COA® and leaf extracts of P. americana and V. amygdalina 
Leaf extracts of P. americana and V. amygdalina collected from Ghana have more 
phytochemicals compared to that of South Africa.  
The finding, of this study, confirm the presence of P. americana and V. amygdalina leaf extracts 
in COA® herbal medicine. It also confirms the profound variations in phytochemicals of P. 
americana and V. amygdalina leaf extracts due to the effects of environmental factors and 
geographical locations.  
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CHAPTER 1: INTRODUCTION   
1.1. Background     
Traditional medicine (TM), identified as native healing, folk medicine, ethnomedicine, or 
complementary and alternative medicine (CAM) is an ancient and culture-bound approach of 
treatment that humanity has utilized to manage and cope with numerous disorders that have 
endangered their lifestyle and survival.1 In previous years, there has been a rapid expansion in 
the industry of plant-based medication. It is acquiring popularity in developing and developed 
nations around the world due to its natural origin and lower side effects.2    
Most users of TM such as Ayurvedic, among others and Traditional African Medicines 
(TAM); probably the most diversified, assume that since TMs have been used for decades, 
they are safer with low toxicity and side effects and allopathic medicines are often less 
ineffective.3 There are challenges in the formulations of herbal medicines, due to lack of 
standardization, identification, lack of quality control and pharmacopoeial standards.4 A 
number of factors affect the quality of herbal medicines, such as quality of raw materials, the 
source of plant material, harvesting, storage processing methods, and other contaminants. 
Stakeholders seek to build quality parameters for collection, handling, processing, production 
and safety of herbal medicines.5    
Published guidelines of standards such as the Ayurvedic Pharmacopoeia, for herbal medicines, 
provides standards for the evaluation of herbal medicines such as external appearance6, ash 
values7, foreign organic matter8, macroscopical and microscopical.9 Moisture content  
indicates the quality and firmness of herbal medicines against deterioration of materials, while 
extractive values and crude fiber are part of the standards for herbal medicines.10,11 In the 
absence of such information on the various plant extracts, it is likely impossible to isolate or 
standardize the active components responsible for the activity.5 Qualitative chemical 
evaluation includes but not limited to, extraction with appropriate solvents, phytochemical 
screening, isolation and characterization of active compounds by gas chromatography-mass 
spectrometry (GC-MS), biological examinations and purification of active compounds for 
their pharmacological importance12 and finds amounts of major classes of phyto-constituents13  
and their toxicity.14     
The greater part of the African population (80%) use TM for their main health care demands. 
A lot of people on the African continent use  TMs, although others combine it with 
conventional drugs.15 Traditional medical practitioners (TMPs) are an essential feature of the 
health-care delivery procedure. The African continent is well known to have a wealthy natural 
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and ethnical diverseness with the noticeable localized difference in therapeutic practices and 
is regarded as the support of humankind. Several local communities of Africa have used plants 
such as Vernonia amygdalina (VA) and Persea americana (PA) in TM for the prevention and 
treatment of diseases such as skin rashes among Human Immunodeficiency Virus (HIV) 
infected persons.16      
COA® herbal medicine (COA®) has been most frequently and widely used by people of South 
African continent for the management of several ailments, such as cancer, diabetes, 
hypertension, and immune support, other diseases and general well-being  and approved by 
local food and drugs board authority (FDA) (FDA/DRID/HMD/HMU/16/0981,). COA® 
contains Vernonia amygdalina, Persea americana, Azadirachta indica, Carica papaya, 
Spondias mombin and Ocimum viride.    
Although COA® is FDA approved in Ghana and widely available in the clinical market, there 
is no written validatory documentation on phytoconstituents of COA® herbal medicine. So, 
there is a need to validate and proof the phytoconstituents present in the marketed COA® that 
are responsible for the pharmacological activities found in leaf extracts of VA and PA.  
1.2 A brief overview of the literature  
A comprehensive literature review has been presented in Chapter Two.    
Two plants V. amygdalina and P. americana were selected out of the six plants present in 
COA® formulation reason being that other candidates were investigating other plants from the 
same medication, and were collected from the different location in Cape Coast (Ghana) and 
Durban (South Africa). Voucher specimens were deposited in the University of KwaZulu-
Natal Herbarium for botanical authentication if required in future.    
Description of Vernonia amygdalina (bitter leaf)    
 Vernonia amygdalina (bitter leaf) has a bitter taste. The bitterness can, however, be abated by 
boiling or by soaking the leaves in several changes of water. The bitter taste is due to anti-
nutritional factors such as alkaloids, saponins, tannins, and glycosides.17 It is a shrub with 
classification as Kingdom; Plantae, Order; Asterales and a member of the Asteraceae family, 
Genus; Vernonia and Species; amygdalina.  It is a short cycled crop, which can be harvested 
at least twice a month depending on environmental conditions.18 On the African continent, 
bitter leaf largely grows in tropical regions such as Ghana, Nigeria and semi-tropical regions 
such as Zimbabwe, Lesotho, and parts of KwaZulu-Natal in South Africa.     
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Figure 1. The aerial part of Vernonia amygdalina.     
    
Description of the.Persea americana     
 Persea americana is commonly known as Aligator pear, Avocado, butter, Avokado 
(Afrikaans), fruit, mparachichi (Swahili), Maluma (South Africa), Paya (Ghana-Twi), and Pia 
(Yoruba). It is classified scientifically as belonging to the Kindom; Plantae, Order; Laurales 
and a member of the Lauraceae family, Genus; Persea and Species; americana. It is commonly 
cultivated in both tropical and subtropical regions in the world. The plant leaf is glossy and 
green, with a bell-shaped fruit (green/brownish).19    
    
Figure 2. The aerial part of Persea americana.  
    
1.3 Problem statement    
The African continent has historical traditions of conventional treatments that require scientific 
exploration with systemic strategies towards detection of chemical substances and their 
bioactive principles to cure disorders. The plant leaf extracts found in COA® have been used 
by indigenous people in African and countries in other continents for the management of 
diseases.     
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There is a need for the provision of a scientific rationale in a form of research to establish the 
phytochemicals responsible for the pharmacological activities of herbal medicines, their 
effectiveness, safety, and toxicity. The methods of analysis of herbal medicines, such as 
phytochemical screening and GC-MS analysis are used in the identification of chemical 
compounds from different solvent extracts of COA® and a standard COA®.     
The geographical area of the leaf extracts used in the preparation of the COA® may have 
differences or similarities in their phytochemicals responsible for the pharmacological 
activities of the COA®. esearch by Inbathamizh et al. (2013), suggested the profound effect of 
geographical properties on the phytochemical composition which further influenced the 
antioxidant potential of Moringa oleifera flowers.19 It is not well known whether the medicinal 
plants in the Cape Coast of Ghana have similarities/and or differences with those plants found 
in Durban.     
This study provides a scientific rationale, on the class of phytochemicals, in standard COA®, 
ethanolic leaf extracts of V. amygdalina and P. americana collected from Cape Coast (Ghana) 
and Durban (South Africa) using phytochemical screening methods. GC-MS analysis of the 
chemical compounds from standard COA®, leaf extracts of V. amygdalina and P. americana 
(Ghana and South Africa) and extracts of COA® in four solvents of extractions, namely 
dichloromethane, hexane, ethanol, and ethyl acetate. 20     
1.4 Research questions,  
The general question of the proposed study is: “What  class of phytochemicals and chemical 
compounds are found in standard COA®, COA® extracts in four solvents and leaf extracts in 
four solvents of V. amygdalina and P. americana collected from Cape Coast (Ghana) and 
Durban    
(South Africa) using phytochemical screening methods and GC-MS?” Specific questions to 
answer the general question are as follows:    
1. What class of phytochemicals are found in standard COA® herbal medicine and ethanolic 
leaf extracts of V. amygdalina and P. americana using phytochemical screening methods?    
2. What chemical compounds/ phytochemicals are found in GC-MS analysis of standard 
COA® herbal medicine compared to four extracts of COA® in DCM, hexane, ethanol and 
ethyl acetate?    
3. What similar chemical compounds/ phytochemicals from GC-MS analysis are contained in 
DCM, hexane, ethanol and ethyl acetate extracts of COA® and leaf extracts of V. 
amygdalina and P. americana from the same four solvents of extractions, collected from 
Cape Coast (Ghana) and Durban (South Africa)?    
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4. What phytochemicals are similar or different from GC-MS analysis of leaf extracts of the 
four solvents of extraction of V. amygdalina and P. americana found in Cape Coast 
(Ghana) and Durban (South Africa)?    
   
1.5 Aim and specific objectives of this study    
The aim of this study is to compare the different phytochemicals and their chemistry found in 
both COA® herbal medicine and crude extracts from V. amygdalina and P. americana found 
in Cape Coast (Ghana) and Durban (South Africa) using phytochemical screening methods 
and GCMS analysis.  
The objectives are:  
1. To identify and classify the chemical composition of the COA® herbal medicine using 
phytochemical screening methods and GC-MS analysis.    
2. To establish the chemical composition of the leaf extract of V. amygdalina and P. 
americana found in Cape Coast (Ghana) and Durban (South Africa) using GC-MS analysis.    
3. To compare the similarities and/or differences of the phytochemicals in the leaf extracts of 
V. amygdalina and P. americana found in Cape Coast (Ghana) and Durban (South Africa) 
and COA® herbal medicine.    
 1.6 General methodology    
1.6.1 Procedure 
This study was done through the classification of phytochemicals, identification of chemical 
compounds and the comparative study of the effect of geographical locations on type and 
number of chemical compounds in the leaf extracts of the medicinal plants using preliminary 
phytochemical screening and choosing the appropriate solvent of extraction for GC-MS 
analysis.   
1.6.2 Study design    
This study is experimental based on the phytochemical analysis of COA® herbal medicine and 
leaf extracts of V. amygdalina and P. americana collected from Cape Coast (Ghana) and 
Durban (South Africa), using phytochemical screening methods in the Medicinal Chemistry 
laboratory at the School of Pharmaceutical Sciences, University of KwaZulu Natal (Westville) 
and GC-MS, at the Mass Spectrometry Laboratory, School of Chemistry University of 
KwaZulu Natal – Pietermaritzburg.    
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1.6.3 Study setting    
Samples of the COA® herbal medicine and the leaves of V. amygdalina and P. americana 
found in Cape Coast (Ghana) and Durban (South Africa).     
1.7 Layout/ structure of the thesis    
The thesis entitled “A comparative chemistry of COA® herbal medicine and leaf extracts 
of Vernonia amygdalina (bitter leaf) and Persea americana (avocado)” that comprises of 
the work done by the author in the Medicinal Chemistry Laboratory at the School of 
Pharmaceutical Sciences, University of KwaZulu -Natal (Westville) and GC-MS, at the Mass 
Spectrometry Laboratory, School of Chemistry University of KwaZulu Natal –
Pietermaritzburg.    
This thesis has been organized into Four Chapters     
Chapter I: Chapter one of this thesis deals with Introduction along with background and a 
brief overview of the literature of the proposed studies. This section gives an overview of the 
statement of the problem, research questions, the aim and objectives of the study. The brief 
methodology has been discussed to achieve specific aim and objectives.     
    
Chapter II: Chapter two is a Review Paper, which has been prepared and submitted 
following the guidelines of the Journal Indian Drugs titled, “Review on ethnomedicinal 
uses, phytochemical constituents and pharmacological evidence on leaf extract of 
Persea americana and Vernonia amygdalina of the African continent”.     
 
Chapter III: Chapter three deals with an Experimental research manuscript. This manuscript 
has been prepared according to South African Journal of Chemistry submission guidelines, 
entitled “A Comparative Chemistry of COA® Herbal Medicine and Leaf Extracts of 
Vernonia amygdalina (bitter leaf) and Persea americana (Avocado) collected from Ghana 
and South Africa”.    
 
 Chapter IV: Chapter Four deals with Synthesis and Discussion of the findings. It 
summarizes the comparative chemistry of COA® herbal medicine and leaf extracts of 
Vernonia amygdalina (bitter leaf) and Persea americana (Avocado) collected from Ghana 
and South Africa in four solvents of extraction (DCM, hexane, ethanol and ethyl acetate). It 
also discusses the impact of geographical location on the phytoconstituents of the plants. 
The finding of the phytoconstituents in herbal formulation motivate researchers to work in 
traditional medicines.    
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After the introduction chapter, a full review paper on Vernonia amygdalina and Persea americana title 
“Review on ethnomedicinal uses, phytochemical constituents and pharmacological evidence on 
leaf extract of Persea americana and Vernonia amygdalina of the African continent” was prepared. 
The paper presented findings of nutrients and phytochemicals and the use of these plants in the treatment 
of ailments as well. This paper was prepared and submitted following the guidelines of the journal 






People on the African continent frequently consume Persea americana (P. americana) and 
Vernonia amygdalina (V. amygdalina) for food and medicinal purposes. The aforementioned 
review is an effort to compile potential ethnomedicinal, phytochemical and pharmacological 
knowledge of the above two plants from the year 2000-2018. A search was carried out using a 
combination of keywords: Persea americana, Vernonia amygdalina, Traditional medicine, 
ethnomedicine, Avocado, Bitter leaf, and Integrated approaches. Published papers in the English 
language were retrieved from the online bibliographical databases: Web of Science, PubMed, 
Google Scholar, Scopus and Cochrane library electronic databases. Findings from this review 
revealed that leaf extract of   P. americana and V. amygdalina have been used in local African 
communities for the management of various diseases. Ethnomedicinal uses, and pharmacological 
properties of leaf extracts of P. americana and V. amygdalina may justify polyherbal formulation 
involving the two plants in the treatment of diseases such as diabetes, hypertension and other 
diseases.    
Keywords: Persea americana Vermonia amygdalina, Traditional medicine, ethnomedicine, 
















 Introduction  
Most modern medicines or drugs have been generated or synthesized from natural products, 
specifically medicinal plants1. The African continent and particularly Southern Africa is a heart 
of medicinal plants with abundant varieties. Statistically, near around 25% of the entire quantity 
of essential plants in the earth is located in Africa and Sahara2. The indigenous communities use 
these medicinal plants as part of their ethnomedicinal practice on the African continent. 
Ethnomedicine is defined as “those beliefs and practices relating to disease, which are the 
products of indigenous cultural developments and are not explicitly derived from the conceptual 
framework of modern medicine”3. The World Health Organization (WHO) defines  traditional 
medicines as” “the sum total of the knowledge, skill, and practices based on the theories, believes 
and experiences indigenous to different cultures, whether explicable or not, used in the 
maintenance of health as well as in the prevention, diagnosis, improvements or treatment of 
physical and mental illness”4. The fifty-sixth world health assembly of WHO on traditional 
medicines indicated that in Ghana, Mali, Nigeria, and Zambia, herbal medicines have been the 
first line of treatment of malaria for more than 60% of children with high fever5. The Africa 
continent is enormous, bestride by the equator and endowed with more than 50,000 distinct known 
species in the sub-Saharan African region alone6. Several countries have used plant resources in 
traditional medicine for the prevention and treatment of diseases. African traditional medicine is 
the oldest, and perhaps the most assorted, of all therapeutic systems7. In the African continent, 
people have used or continue to use traditional medicines for the management and /or treatment 
of ailments in both humans and livestock8,9. The most preferred part of medicinal plants for 
treatments in Traditional African Medicines (TAM) is the young succulent, green and fresh 
leaves. Although other parts such as the roots, stems, and flowers are used. In Traditional African 
Medicines, medicines made from the leaves of plants are largely water-based organic decoction 
extract used as tonic drinks10.  
Majority of the people of Ghana and Africa still give preferences to traditional medicine for their 
health needs11. In South Africa, a great proportion of the population relies on plant-derived 
remedies to treat diseases12. A large proportion of the South African population in the Eastern 
Cape still depend on traditional herbal medicines to manage numerous diseases such as skin 
rashes among Human Immunodeficiency Virus (HIV) infected persons13.  
Persea americana (avocado), belonging to the Lauraceae family and cultivated in both tropical 
and subtropical regions in the world is used by indigenous African communities for the treatment 
of numerous disease regimes14. The plant has a simple glossy, green leaf with fruits in bell shape 
(largely greenish or brownish)15.  
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Ethnomedicinal study of P. americana conducted in South Africa16, Uganda17 and Cameroon18 
respectively reported the use of root, seed and leaf extracts in the treatment of diabetes. The use 
of leaf extracts of P. americana in the treatment of malaria has been reported in Ghana19 and 
Nigeria20, 21. Other ethnomedicinal treatments include but are not limited to hypertension and 
typhoid. 
The consumption of the fruit as food and the use of different parts of the plant in the treatment of 
diseases by local communities around the world have been reported.  It has been reported the use 
of the fruit in the preparation of baby food in most African communities22. Leaves of P. americana 
are used by the people of Bukavu city, Democratic Republic of Congo, in the treatment of 
ailments such as diarrhea, hypertension and cough conditions23. A study conducted in Nigeria 
reported the use of dried leaves in the treatment of hypertension24.   
Amaechina along with his co-workers reported the pharmacological use of aqueous seed extracts 
of P. Americana in the reduction of blood pressure of normotensive rabbits and rats in Nigeria25. 
Analgesic and anti-inflammatory effects of aqueous leaf extract have been reported in mice. The 
extract was able to raise the pain threshold to heat in the animals26. Leaf Extract of P. americana 
has been used as a natural supplementary remedy in essential hypertension and certain cases of 
cardiac dysfunctions in rural Africa communities 27.  
Natural bioactive components (phytochemicals) in P. americana serve as nutrients to protect the 
plant against diseases28.  Major chemical components found in different parts of the plant reported 
to date include alkaloids, flavonoids, saponins, phenols, terpenoid, glycosides, furan ring-
containing derivatives, and coumarin29-33. Alkaloids, flavonoids, saponins, and phenols are 
responsible for analgesic and antispasmodic, anti-oxidant, antibiotic and antidiabetic activities 
respectively34,35. Isorhamnetin, luteolin, rutin, quercetin, and apigenin have been isolated 
phytochemicals from leaves of dried avocado36. Among these isorhamnetin and quercetin showed 
anti-oxidant activities37.  
 Another medicinal plant of interest for this review is V. Vernonia amygdalina (bitter leaf). It 
belongs to the Asteraceae family and grown or cultivated on the African continent in tropical 
regions such as Ghana, Nigeria, Cameroon and semi-tropical regions such as Zimbabwe, Lesotho, 
Mozambique and certain parts of KwaZulu-Natal in South Africa38.  
In ethnomedicine, leaf extracts of V. amygdalina have been used in Ghana and Nigeria for their 
immune stimulating activity in individuals with HIV or immunocompromised condition such as 
cancer or diabetes. Decoctions of leaves of V. amygdalina have been used in treatments and 
prevention of ailments including but not limited to piles, diabetes, kidney diseases, malaria, 
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hiccups, fever, high blood pressure, and stomach discomfort9,39. A review paper has been 
published which confirmed that V. amygdalina has a low or no toxicity40.   
Researchers have isolated numerous phytochemicals with potent bioactivity from leaves of V. 
amygdalina including sesquiterpene edotides, lactones, flavonoids: Luteolin-7-O-glucuronide, 
Luteolin 7-O-glucoside, and glycosides38,41. Luteolin and glycosides have been reported to have 
anti-microbial, antioxidant activities and in vivo biological activity as a cancer chemo preventive 
agent. 42.   
Methods  
Search strategy  
Databases and specific keywords  
Web of Science, Google Scholar, Pub-Chem, Pub-Med and Cochrane library electronic databases 
were explored for the period 2000-2018.  Specific keywords used in carrying out the search 
included the following: use of Persea americana and Vernonia amygdalina in disease 
management, avocado, bitter leaf, ethnomedicinal use of Persea americana and Vernonia 
amygdalina, phytochemical constituents and pharmacological activities of Persea americana and 
Vernonia amygdalina.  
Inclusion criteria applied to studies performed on the African continent that reported 
ethnomedicinal uses, phytochemical constituents and pharmacological activities of Persea 
americana and Vernonia amygdalina.  
Exclusion criteria included publications in a language other than English, not related to our study 
and duplicates.  
 
Selection of potential research papers  
About three hundred eligible papers were produced according to the search benchmarks 
implemented via online out of which 142 made the list as presented in Figure 1 among which 92 
articles/papers were used in the review findings, while the rest were used in the introduction and 
discussion.  
















Records identified through database searching (Web of science, Google scholar, 
































Records after duplicates removed  
(n =93) 
Records screened  
(n =208) 
Records excluded  
(n = 30) 
Full-text articles/papers assessed for eligibility  
(n = 178) 
Full-text articles/papers excluded, with reasons; 
articles/papers from countries other than Africa and 
articles not in English  
(n =36) 
Qualitative Assessment of eligible articles/papers  
(n = 142) 
Reasons for exclusion: 
 Duplications of work 
 Not in English or African language 








Analysis of data extracted from search criteria  
Selected papers taken into consideration for this review were analyzed based on the following: 
Country, year of study, study design, number of participants, research period, ethnomedicinal use, 
treatment modalities/part used and/ or side effects of using Persea americana and Vernonia 
amygdalina therapy. Moreover, pharmacological action and phytochemical chemical constituents 
of the plant reported in various studies (Table 1, 2, 3, 4, 5, and 6) were taken into consideration.  
Review findings  
Ethnomedicinal uses for Persea americana and Vernonia amygdalina  
Table 1 presents the findings from this review about leaf extracts of Persea americana which 
were commonly used in ethnomedical practices by local communities in African countries for the 
management of diabetes, hypertension, malaria and other diseases, without no documented side 





















Disease(s) reportedly treated in different 
local communities 
References 
NA Ghana Ethnomedicinal survey NA Paya ahaban Leaves Hypertension 44  
April 2004 Kenya Ethnobotanical survey 30 NA Leaves Diabetes 45 
NA Cameroon Survey, questionnaire 137 NA Leaves Diabetes 18 
NA Cameroon Cross-sectional, Self-
structured questionnaire 
200 NA Seed and bark Toothache 46 
NA Ivory Coast Ethnobotanical survey NA Awuca, Pya, Afouca Leaves Malaria 43 
April-May 2013 Uganda Ethnobotanical survey 338 Ovakedo Seeds Diabetes 17 
Sept.-Dec.2013 Ghana Semi-structured interviews 40 Paya Leaves 
 
Malaria 19 
Feb-June 2012 Nigeria Ethnobotanical survey 50 Apoka Leaves, root Typhoid 47 
Feb 2011-Dec 2012 Congo DR Ethnobotanical survey NA Ivoka Leaves Diarrhea, Hypertension, Cough 23 
NA South Africa Ethnobotanical survey 54 NA Seed Skin Diseases 13 
May-Sept. 2012 Nigeria Ethnobotanical survey 250 Pia Leaves Malaria 21 
June 2009 to March 
2010 
Congo Leaves and fruit  Wines 47 Ivoka (mashi)avokati 
(Swahili) 
Leaves and fruits Constipation, Kidney, Various Pains 48 
NA Nigeria Ethnobotanical survey 151 Igba, apoka Leaves Malaria 49 
NA South Africa Ethnobotanical survey 52 Moafokhathe Root  Diabetes 16  
May-Sept 2007 Burkina Faso Interviews 41 Avoka-tiiya Leaves Sedative 50 
NA Nigeria Questionnaire, interviews 120 Pia, apoka  Leaves Blood Pressure 51 
March-June 2008 Nigeria Semi structured 
questionnaires 





Cameroon Ethnobotanical survey 412 NA Bark Syphilis 52 
NA Ivory Coast Ethnobotanical survey 32 NA Seed Diabetes 53 
Jan. 2007-April 
2008 
Nigeria Questionnaire NA NA Leaves Hypertension 54 
NA Nigeria Ethnobotanical survey NA NA Dried leaves Hypertension 24 
Feb. 2002-Dec 
2005 
Guinea Ethnobotanical survey NA Piya Leaves Anti-Bacterial 55 
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Table 2 presents the findings from this review about the ethnobotanical surveys and ethnomedicinal uses of Vernonia amygdalina in different local 
communities on the African continent. Leaf extracts of this plant have been used for the managements of various diseases such as malaria. 
Table 2. Ethnomedicinal use of Vernonia amygdalina in the treatment of diseases on the African continent. 
Research Time 
Frame 
Country Study Design Sample Size  Local Name Of 
Vernonia amygdalina 
Plants Part Used Disease(s) References 
September 2011-
February 2012 
Ethiopia Ethnobotanical survey 189 Hecho Leaves Antimalarial 56 
NA Cameroon Survey 
questionnaire 





Nigeria Ethnobotanical survey NA Ewuro/aromagbo Leaves Asthma 57 
September 2011-
March 2012 
Nigeria Ethnobotanical survey 10 Shiwaka Leaves Chickenpox, 
Hepatitis, Measles, Rabies 
58 
NA Nigeria Ethnobotanical survey NA Shiwaka Stem/Root Pile, diarrhea, High-Blood 
Pressure 
59 
NA Nigeria Ethnobotanical survey NA Ebe oboyiwo Leaves Diabetes 60 
NA Nigeria Ethnomedical 
Survey 





108 Bekantsu Leaves Menstrual cramps 62 
NA Nigeria Survey 
questionnaire 
208 Ewuro Leaves Measles, Jaundice, 
Chickenpox 
63 
NA Nigeria Survey 
questionnaire 





In vivo and In vitro studies on Persea americana and Vernonia amygdalina with 
pharmacological actions  
Table 3 presents the findings of this review about the pharmacological activities of leaf extracts of 
Persea americana in various diseases. Most of the studies reported anti-microbial, anti-diabetic, 
antihypertensive and other pharmacological properties.  
Table 4 presents the findings of this review about the pharmacological activities of leaf extracts of 




Table 3. Pharmacological action of Persea americana on cell lines, animal models and human subjects. 
Country Study 
Design 
Cell Lines, Animal Models And 
Human Subjects 
Treatment Modalities Pharmacological 
Action 
Outcomes References 
Nigeria In vitro Clinical isolates (Bacillus cereus, 
Bacillus subtilis, Pseudomonas 
aeruginosa, Salmonella typhi, 
Staphylococcus aureus, Shigella 
flexneri, Escherichia coli, Candida 
albicans) 
Leaf extracts Anti-microbial Inhibition of growth  isolates 65 
Nigeria In vitro alpha-amylase and alpha-
glucosidase 
Aqueous extract seeds Anti-diabetic Inhibition of key enzymes for 
carbohydrate digestion 
66 
Nigeria In vivo Mice Ethanolic extract  Neuropharmacological Depressant effect on CNS 67  
Nigeria In vivo Wistar rats Ethanol extract of seed hepatoprotective and 
hemopoietic activity 
The decrease in liver enzymes and an 
increase in hematological parameters 
68 
Ghana In vitro Salmonella Leaf extract Anti-microbial Inhibition in the agar diffusion assay 69 
Nigeria In vivo Albino Mice Aqueous leaf extract  Activated partial 
thromboplastin 
Increase in prothrombin time 15 
Ghana In vitro Chloroquine-sensitive 3D7 
Plasmodium falciparum and 
chloroquine-resistant W2 
Plasmodium falciparum strains 
Aqueous extract of 
leaves 
Antimalarial Antiplasmodial activity against the 
chloroquine-sensitive 3d7 p.  Plasmodium 
falciparum 
70 
Nigeria In vitro Bacteria isolates Methanolic leaf and 
bark extract 
Antibacterial infections Inhibition of growth of bacteria 71 
Nigeria In vivo CCl4 induced damage male albino 
rats 
Aqueous.extract  Hepatoprotective 
activity 
Bradychardia, vasorelaxation, and 
hypotension   
72 
Cameroon In vivo Rats Aqueous leaf extract of 
P. americana  
Anti-hypertensive Protection against liver and kidney 
damage as a result of increment of 
oxidative status by the extract 
73 
Nigeria In vivo Nonpregnant rat uterus Aqueous extract of P. 
americana seed 





Human Liquid extract of leaf Anti-hypertensive Reduction in cholesterol levels in patients 75 
Nigeria In vitro alpha-amylase and alpha-
glucosidase 
Phenolic leaf and fruit 
extracts 
Antidiabetic Inhibition of enzymes linked to type 2 
diabetes 
76 
Nigeria In vitro Sorghum bicolor seed germinating 
rapidly 
The methanol extract of 
leave and  seed 
Anti-tumor Inhibition of germination of seed 77 
Nigeria In vitro Pancreatic rats(Fe2+ induced lipid 
peroxidation) 
Phenolic extract of leaf The inhibitory effect on 
Fe2+ induced lipid 
peroxidation 
Protect the pancreas from Fe2+ induced 




Nigeria In vivo Wistar rats Chloroform-methanol 
extracts of the seeds 
Antispasmodic effect 
 
Decreases in the gastro-intestinal motility  
78 
Nigeria In vivo Wistar rats Fruit extracts Cardio vascular disease 
inhibitor 
Decreased total cholesterol 79 
Nigeria In vitro MCF-7 cell line Stem bark Antiproliferative and  
pro-apoptotic activities 
Lacks antiproliferative and apoptotic 
effects in mcf-7 cell line 
80 
Nigeria In vivo Diabetic Rats Aqueous seed extract. Anti-diabetic  81 
Nigeria In vitro Cancer cells Methanolic extracts Cell proliferative 
activity 
Anti proliferative estrogen receptor blood 
cancer cells 
82 
Nigeria In vitro HBAs and HbSS blood samples Alkaline and alcoholic 
extracts 
Anti-sickling Reduction in the number of sickle cells 83 
Nigeria In vivo Rats Aqueous seed extract Hypotensive Reduced bp  in normotensive beat rates 84 
Nigeria In vitro Escherichia coli, Klebsiella 
pneumonia, Bacillus subtilis, 
Streptococcus pyogenes,  
Seed extracts. Anti-microbial Inhibition of growth of microbes 85 
South Africa In vivo STZ induced diabetic rats Ethanolic leaf extracts Anti-diabetic Reduced urine flow and electrolyte 
excretion rate 
86 
Nigeria In vivo Rats Leaf extracts Anti-diabetic and 
hypocholesterolemic 
Lower plasma glucose and influence lipid 
metabolism 
87 
South Africa In vivo Guinea pig(Cavia porcellus) Aqueous leaf extract Hypotensive Caused bradychardia and vasorelaxation 88 
South Africa In vivo Mice Aqueous leaf extract Anti-convulsant Enhance gaba neurotransmission on the 
brain 
89 
South Africa In vitro Male Balb C mice (Mus 
domesticus) 
Intraperitoneal 
injections aqueous leaf 
extracts 
Anticonvulsant effect Graded doses in mice gave an ld50 value 
of 1336±103mg/kg indicating non-toxicity 
in mice. 
89 
Nigeria In vivo Isolated thoracic rat aorta Aqueous leaf extracts Vasorelaxant Vasoconstriction due to inhibition of ca2+  36 
Nigeria In vivo Albino Rats Aqueous leaf extracts Anti-ulcer 
 
Anti-ulcer activity against experimentally 




Table 4. Pharmacological action of Vernonia amygdalina on cell lines, animal models and human subjects. 
Country Study design Cell lines, animal 
models and human 
subjects 
Treatment modalities Pharmacological 
action 
Outcomes/side effects References 
Nigeria In vitro Trichoderma sp. Chewing of stem  Anti-microbial 
Activity 
Effective in inhibiting both bacterial and 
fungal infections. 
91 




Inhibition by disk diffusion 










controlled clinical trial 
40 HIV-infected 
patients on ART 
regime for at least 1 
year with CD4 line 
120-212 
Oral:2 times daily of leaf 
extracts for 4 months 
Immunological 
effect 
Immune stimulating activity of leaf extracts 
and its combination with immunace®  
93 
Nigeria In vivo  Albino Wister rats 
(Rattus novergicus) 
Methanolic leaf extracts   Antioxidant activity Leaf extracts contain contains phenolics and 
flavonoids and possess hepatoprotection 
effect against rat organ damage 
94 
Nigeria In vivo Albino Wistar 
rats(both sexes) 
Gastric intubation in a 12 h 
cycle  for 
14 days 
Anti-diabetic Elevated blood glucose decreased compared 
to both normal control and alloxan treatment 
after 14 days. 
34 
Nigeria In vivo Beans weevil 
(Acanthoscelide. 
obtectus) 
Seeds sprayed with different 




The average mortality indicated that 4.00% 
concentration resulted in higher toxicity of 
33.60 in Acanthoscelide. 
Obtectus.  
95 
Uganda In Vivo (4-Day 
Suppression Test) and 
(Rane Test) 
Human patients  
 
 1 L of freshly made infusion 
daily to be taken as 250 mL, 
4 times daily for 7 days 
Anti-malarial There was no evidence of significant side-
effects or toxicity from the medication.  
96 
Nigeria In Vivo Clinical cross-
sectional work 
comprising sixteen 
humans (8 female and 
8 males) 
Oral administration using 
the squeeze-wash-drink 
method. 
Anti-diabetic V. amygdalina elicited significant reductions 
(p<0.05) in blood glucose levels at most 
postprandial time points and for area-under-




Phytochemical constituents of Persea americana and Vernonia amygdalina and their 
pharmacological actions  
Table 5 presents the findings of this review about the phytochemical constituents and biological 
activities of leaf extracts of Persea americana. Most of the studies reported the presence of 
alkaloids, flavonoids, and saponins with largely anti-oxidant activity.  
Table 6 presents the findings of this review about the phytochemical constituents and biological 
activities of leaf extracts of Vernonia amygdalina Most of the studies reported the presence of 









Country Part Used Phytochemicals 
 Present 
Outcomes References 
Nigeria Seed Tannin, total oxalate, phytate Good source of nutrients 98 
Nigeria Leaves Alkaloids, tannins, cardiac glycosides, anthraquinones, flavonoids, 
proanthocyanidins, phytates and saponins 
Antioxidant activity 99 
Nigeria Seed Alkaloids, flavonoids, tannins, saponins, 
Oxalates and phytates 
Unsaturated fat good for heart 100 
Nigeria Seed Saponins, phenols, tannins, flavonoids, alkaloids, steroids and glycosides Antioxidant activity 101 
Nigeria Aqueous and 
chloroform leaf 
extracts. 
Saponins, flavonoids, tannins and cardiac glycosides Effect on tumor producing cells 102 
Nigeria Seed Phenols, flavonoids and pro-anthocyanidin Antioxidant activity 103 
Nigeria Leaves, seed and bark  Leaves: moderately high amounts of flavonoids, proteins, trace amounts of 
alkaloids, terpenes and tannins 
 Bark: moderately high concentrations of alkaloids, flavonoids, saponins and 
trace amounts of proteins  
Seed: moderately high concentration of flavonoids, proteins, alkaloids and in 
trace amounts carbohydrate 
Protease inhibitor 104 
Nigeria Leaves Alkaloids, terpenoids, flavonoids, saponins, tannins phytates, oxalate. Antioxidant activity 105 
Nigeria Leaf extracts Alkaloids, tannins, flavonoids, cardiac glycosides, saponins, terpenes and 
steroids 
Inhibitory activity responsible for anti-
tumor related complications 
106 
Nigeria Leaf extracts Sterols, tannin, saponin, flavonoids, alkaloids, phenols, phlobatannins, 
anthraquinones, triterpenes, cardiac glycosides, phytates, oxalate 
Antioxidant activity 107 
Nigeria Seed Alkaloids, saponins, tannins, flavonoids, cyanogenic glycosides Na 108 
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Table 6. Phytochemical constituents observed in Vernonia amygdalina in African countries. 
Country Part used Phytochemicals present Outcomes References 
Nigeria Stem 
(ethanol extract) 
Anthraquinones, tannins, flavonoids, terpenoids, saponins 
alkaloids 
Ethanol extract showed higher inhibitory effects on most of the test organisms 
as compared with chloroform and ethyl acetate extracts 
91 
Nigeria Leaves Flavonoids, saponins, alkaloids, beta-carotene, ascorbic acid 
 
Possible supplement in animal nutrition and it justifies their use in traditional 
medicines for the treatment of different diseases 
109 
Nigeria Leaves Tannins, phlobatanin, flavonoids, alkaloids, glycosides, 
cyanogenic, glycosides, anthraquinone, terpenoids, saponin 
polyphenols, cardenolide 
Might be a source of active antimicrobial agents for the development of drugs 
for the treatment of these microorganisms. 
92 
Nigeria Stem and root bark 
Extracts 
Alkaloids, tannins, flavonoids, saponins, and hydrocyanide The extracts serve a source of pharmacologically active. 110 
Nigeria Stem and root bark 
Extracts 
Saponins, alkaloids, flavonoids, hydrocyanide and trace 
amounts of tannins 
Source of pharmacologically active phytochemicals 110 
Nigeria Root extract Alkaloids, glycosides Saponins, flavanoids  
Reducing sugar, steroids 
Elevated blood glucose (p<0.01), compared to both normal control and pre-
alloxan treatment value, Decreased (p<0.01)  
34 
Nigeria Stem extract  Alkaloids, glycosides, flavonoids, Reducing sugar, 
polyphenols steroids 
Elevated blood glucose (p<0.01), compared to both normal control and pre-
alloxan treatment value, Decreased (p<0.01), 
34 
Nigeria Stem extract  Alkaloids, glycosides  
Saponins, polyphenols, reducing sugar, steroids 
Elevated blood glucose (p<0.01), compared to both normal control and pre-
alloxan treatment value, Decreased (p<0.01), 
34 
Nigeria Leaf extract  Alkaloids, glycosides, flavanoids  
Reducing sugar, polyphenols steroids, tannins hydroxymethyl 
anthraquinones 
Elevated blood glucose (p<0.01), compared to both normal control and pre-
alloxan treatment value, Decreased (p<0.01), 
34 
Nigeria Leaf extract Alkaloids, glycosides, flavanoids  
Reducing sugar, polyphenols steroids, 
Elevated blood glucose (p<0.01), compared to both normal control and pre-
alloxan treatment value, 
Decreased (p<0.01), 
34 
Nigeria Leaf  Alkaloids, flavonoids, saponins, tannins  
Phlobatannins, terpenoids, cardiac glycosides 
Average mortality showed that 4.00% concentration resulted in higher toxicity 
of 33.60 in A. obtectus while 





Although progress and advances are made for the treatment of diseases with orthodox 
medicines, largely African patients resort to the use of ethnomedicine for solutions to treatments 
such as HIV/AIDS, cancer and diabetes111,112. In ethnomedicine on the African continent, 
medicines made from the leaves of plants are largely water-based organic decoction extract used 
as tonic drink39,9.  
This review found that Persea americana has been used in ethnomedicine in the African 
continent. In Nigeria, the use of leaves of Persea americana as a therapy for malaria by a 
population in Ogun state20. It has been reported the use of leaf extracts of Persea americana in 
the treatment of diabetes by a population in Nyeri county45, while Tsabang et al., indicated the 
treatment of this same disease by people in Cameroon with leaves as a therapy18. This is in 
agreement with a research carried out in Latin American countries in which indicated the use of 
leaves by a population113.  It is substantial to point out that there were not much reported side 
effects because of the use of Persea americana (whole or part) in the treatment of diseases 
across the African continent. This is an affirmation of the reason why the indigenous population 
in Africa resort to alternative medicine in the management of diseases. Limited side effects of 
ethnomedicine are one of the reasons for the greater use of herbal medicines among African 
ethnic communities. 114. An ethnobotanical survey conducted in Cameroon16 and Kenya45 
revealed the use of leaves of Persea americana in the treatment of diabetes by patients.  
In Trinidad and Tobago, an ethnobotanical interviews conducted from 1996–2000 with thirty 
male and female respondents concluded that Persea americana among other medicinal plants 
have been used for hypertension and diabetic treatment115. In Guatemala indigenous population 
consumption of the fruit as food and the use of different parts of the plant in the treatment of 
diseases such as diarrhoea116. Persea americana leaves are used in the treatment of diabetes in 
Latin America113.  
 Vernonia amygdalina had a lot of health-promoting benefits for human use as well as the 
poultry industry. Leaf extracts of V. amygdalina had immune stimulating activity in individuals 
with HIV or immunocompromised conditions such as cancer or diabetes40. Leaf decoctions of 
V. amygdalina have been used in ethno medicine in the treatments of ailments such as diabetes, 
malaria, hypertension, fever, high blood pressure, kidney diseases, immunological effect, 
insecticidal properties and syphilis within the African community9,39,117, Leaf extracts of V. 
amygdalina in Nigeria34 are used in ethnomedicines for treatment of diabetes; this is in 
agreement with Okolie et al.97. An ethnobotanical survey in Nigeria found that leaf extracts are 
used to treat the same disease60. This is confirmed by an ethnobotanical survey in Nigeria for 
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diabetic treatment with Vernonia amygdalina leaf extracts118. Aqueous leaf extracts of V. 
amygdalina are used in the treatment of malaria in Ghana. 119 This use is in agreement with 
report observations by Asnake et al, in Ethiopia56 and Nigeria120.  
Pharmacological research carried out in Ghana indicated the use of leaves of Persea americana 
and as an antimalarial agent19.  In vivo and in vitro results in Table 3 justify the reason why 
indigenous folks in African communities lean on a specific part of Persea americana in the 
treatment of certain kind of disease. Hypoglycemic effect of P. americana leaf extracts in rats. 
Observed data revealed after this same study indicated the reduction of plasma glucose in the 
animals.  In a similar study conducted in South Africa, ethanolic leaf extract indicated a 
hypoglycemic effect on Streptozotocin (STZ) induced diabetic rats.121.  A reduction in urine 
flow and electrolyte excretion rates with the animals were observed122. An in vitro study in 
Mexico on antioxidant activity against  2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic 
acid)(ABTS) radical of peel, pulp and seed ethyl acetate, acetone, and methanolic extracts of 
Persea americana , concluded that there are natural source phenolics with high antioxidant and 
antimicrobial potential123.  
Interestingly, there is a linkage between ethnomedicinal use of leaves of P. americana and 
pharmacological actions reported in Tables 1 and 3 that reveal their use in the treatment of 
diabetes in African communities.    
In pharmacological activities, reported antioxidant activity of V. amygdalina leaf extracts in 
vitro with Staphylococcus aureus and Pseudomonas aeruginosa bacteria35,92. Observed data 
revealed indicated the reduction of plasma glucose in the animals by the use of V. amygdalina 
leaf extracts34. Clinical cross-sectional work on humans97 as well as in vivo in albino Wistar 
rats34 (both sexes) in Nigeria indicated the treatment of diabetes using leaf extracts of V. 
amygdalina. These results are in accord with Osinubi, (2007) who reported that aqueous leaf 
extracts of V. amygdalina indicate a substantial blood-glucose-lowering potential in both 
normoglycaemic and alloxan-induced diabetic male Sprague-Dawley rats comparable to that in 
chlorpropamide-treated rats124for  its anti-diabetic activity124. An in vitro study in Nigeria using 
Staphylococcus aureus and Pseudomonas aeruginosa bacteria reported anti- oxidant activity of 
leaf extracts of V. amygdalina92. The anti-oxidant activity of aqueous and methanolic leaf 
extracts of V. amygdalina as reported in an in vitro assay125 is in agreement with Johnson et al.92 
In Nigeria in an in vivo study, involving albino rats (Rattus novergicus) orally administered 
with methanolic leaf extracts showed anti- oxidant activity94. The result of in vitro Trichoderma 
sp assay in Nigeria indicated that leaf extracts and the chewing of the stem of V. amygdalina 
have anti-microbial activity, which is effective in inhibiting both bacterial and fungal 
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infections91,126. An in vitro study using Ascaris suum conducted in Uganda among pastoralist 
communities showed that ethanolic and water leaf extracts of V. amygdalina A study on an in 
vitro study against Ascaris suum that ethanolic and water extracts of V. amygdalina have 
anthelmintic activity in the cattle.127  In Malaysia presented an in vivo study on Nulliparous and 
non-pregnant female SD rats (Rattus norvegicus), with a single oral doses of V. amygdalina 
aqueous extract at progressive dose of 175 mg/kg, 550 mg/kg, 2000 mg/kg and 5000 mg/kg of 
Body Weight (BW) showed antioxidant activity35. They further indicated that the presence of 
flavonoids have a potent antioxidant together with terpenoids may have contributed to the lack 
of direct organ toxicity by free radical scavenging activities. V. amygdalina have 
antihyperglycemic effect; polyphenols in the extract may be the candidates that are responsible 
for the above-mentioned biological activities128.  A review paper indicated a polyherbal 
formulation in Ghana containing only P. americana and V. amygdalina is under in-vivo 
evaluation for anti-hypertensive129. The reported phytochemicals present in P.  americana are 
in agreement with what other researchers reported in different parts of the globe31,33,130,131. The 
abundance of these phytochemicals in P. americana contribute to biological activities when 
applied in humans. The presence of two glucosylated abscisic acid derivate in P. americana 
seed could help improve symptoms of type 2 diabetes32. The potential of triterpenoid of P. 
americana seed as an anticancer agent is being investigated14. The growth inhibitory effects 
exhibited by leaves of  P. americana examined on the radicle length of guinea corn bicolor seed 
make it a potential antitumor agent and have appreciable phytochemical constituents as 
indicated in Nigeria but exhibited low levels of toxicity105. The presence of two glucosylated 
abscisic acid derivate in P. americana seed could help improve symptoms of type 2 diabetes32. 
The potential of triterpenoid of P. americana seed as an anticancer agent is being investigated. 
The growth inhibitory effects exhibited by leaves of P. americana examined on the radicle 
length of guinea corn bicolor seed make it a potential antitumor agent106. It has been further 
reported that P. americana has a rich mineral content and recommended it to be part of human 
and animal foods formulations105. However, veterinarians must not recommend leaves of P. 
americana as a feed ration for horses. Natural instances of avocado poisoning were reported in 
Australia when horses were fed on fruits and leaves of the plant. Mastitis was the condition 
observed in lactating Arabian mores after the incident132.   
.Vernonia amygdalina contain medicinally important bioactive compounds that show inert 
potentials for use as a possible supplement in animal nutrition and it justifies their use in 
traditional medicines for the treatment of different diseases109.  A large number of researchers 
have isolated numerous phytochemicals with potent bioactivity from leaves of V. amygdalina 
including sesquiterpene edotides and lactones, flavonoids: Luteolin-7-O-glucuronide, Luteolin 
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7-O-glucoside, and glycosides38,41. Phytochemicals have been isolated from leaves of dried 
avocado that yielded isorhamnetin, luteolin, rutin, quercetin, and apigenin133. The previous 
studies had demonstrated that vernodalin from V. amygdalina leaf have antitumor activity 
Luteolin-7-O-glucuronide (the most abundant compound) have antioxidant activity40.   
 A preliminary phytochemical screening conducted in Nigeria of ethanolic stem extracts of 
Vernonia amygdalin yielded anthraquinones, tannins, flavonoids, terpenoids, saponins.91 Th is 
in contrast with investigations conducted by Atangwho et al. (2010), that indicated the presence 
of alkaloids, glycosides, flavonoids, reducing sugar, polyphenols, and steroids. Although 
aqueous stem extracts have alkaloids, glycosides, saponins, polyphenols, reducing sugar, 
steroids34. Stems and root barks extract analysis found alkaloids, tannins, flavonoids, saponins, 
and hydrocyanide present110. This result obtained is in line with Atangwho et al. (2010) in the 
ethanolic and aqueous root extracts of V. amygdalin obtaining alkaloids, glycosides saponins, 
flavonoids, reducing sugar and steroids34. The same researchers reported that ethanolic leaf 
extracts of V. amygdalina had alkaloids, glycosides, flavonoids reducing sugar, polyphenols, 
steroids, tannins hydroxymethyl anthraquinones, while the aqueous leaf extracts of the same 
plant produced alkaloids, glycosides, flavonoids, reducing sugar, polyphenols, and steroids34. 
Alkaloids exhibit analgesic and antispasmodic activities while tannins are able to eliminate 
protein deficiency syndrome known as “kwashiorkor’’. 105 Further to some of these activities, it 
has previously been established that tannins have wound-healing property in humans. 134.    
Flavonoids have good antioxidant potential that helps with the reduction of oxidative stress135. 
Saponins serve as natural antibiotics for the treatment of fungal infections100. Phenols and 
proanthocyanidin are such a good source of harnessing antioxidants103.  
The differences in the types of phytochemicals may be due to the geographical location of the 
plants. Geographical factors may influence the presence of primary and secondary metabolites 
found in herbal medicines136. Sampaio et al. (2016), further argues that variations are very useful 
in the chemical characterization of plants of the same species collected from different regions. 
Due to environmental factors, species of the same plant but growing in different environmental 
conditions may have substantial differences and/ or similarities in the production and 
accumulation of primary and secondary metabolites caused by chemical interactions between 
plants and the environment. Processes of variations involved long term acclimation, seasonal 
differences related to phenology or environmental changes in the biotic and abiotic factors, 
geographical differences involving different populations (genetic differences within a plant 
species), or different environmental conditions of the growth location of the species 
individuals136. Environmental factors had an influence on the types and contents of 
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phytochemicals in plants137. Liu et al. (2016) indicated that altitude and annual mean 
temperatures were significantly and negatively correlated to the tannin content and the content 
of total phenolics respectively. While annual sunshine duration and altitude were significantly 
and positively correlated to the flavonoids, rutin content, and antioxidant activity. In addition, 
altitude was significantly and positively correlated to the content of total phenolic 137.  
 Implications of findings for future research into Persea americana and Vernonia 
amygdalina  
The use of Persea americana and Vernonia amygdalina as food and in the treatment of diseases 
by people on the African continent emphasize the significance of these plants. However, 
standardization of the whole plant is essential to evaluate the safety and efficacy of using the 
plant and phytochemical evaluation is key towards achieving that goal138.  
Limitations of this review  
This review is about research-based studies on Persea americana and Vernonia amygdalina 
within the African continent reported in the 21st century.  Studies included in this narrative 
review were centered on recognized quality of valuation since this was not a systematic review, 
which solely relies on expert judgment.  Identified articles retrieved from diverse kinds of 
journals included both quantitative and qualitative work.  A bias towards articles published in 
English was taken into consideration. In terms of publications on Vernonia amygdalina more 
recent publishers (between 2010 and 2018) were used due to the reason that over hundreds of 
papers were retrieved and most had similar outcomes and researched in Nigeria.  
Conclusions  
Various drugs have been produced and used in the national and international market by 
following the traditional system and its ethnopharmacological application. The traditional 
system of medicine remains the most ancient yet living traditions for the treatment of various 
diseases. The increased popularity of alternative medicine can be attributed to the emergence of 
a number of factors. Primarily, most people have resorted to the use of alternative medicine in 
the belief that they stand to accrue benefits that are not available in conventional medicine and 
related therapeutic interventions.   
Findings from this review revealed that P. americana and V. amygdalina are rich in nutrients 
and phytochemicals and therefore not only good for human consumption but for treatment of 
ailments as well. Traditional healers have an unmistakable and crucial role to play in building 
the health system in South Africa and strengthening and supporting the national response to 
different disease conditions. Ethnomedicinal uses, and pharmacological properties of leaf 
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extracts of P. americana and V. amygdalina may justify polyherbal formulation involving the 
two plants in the treatment of diseases such as diabetes and HIV/AIDS.  
Further studies are needed to determine the chemistry of polyherbal mixtures claiming to contain 
leaf extracts of Persea americana, Vernonia amygdalina and /or other medicinal plants. In 
addition, the chemical composition of these plants found in different geographical areas needs 
to be investigated.  
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This chapter, following the full review paper is presented on the phytochemical compositions of COA® 
herbal medicine and crude leaf extracts of Vernonia amygdalina (bitter leaf) and Persea 
americana (Avocado) titled “A comparison of phytochemical composition of COA®herbal 
medicine and crude leaf extracts of Vernonia amygdalina (bitter leaf) and Persea 
americana (Avocado) collected from Cape Coast, Ghana and Durban, South Africa” was 
prepared, submitted and under review following the guidelines of the South African Journal of 
Chemistry. The paper indicated that COA® herbal medicine contains leaf extracts of V. amygdalina 
and P. americana and that geographical and environmental factors have profound effect on the 







Centre of awareness (COA®) herbal medicine is made from six different leaf extracts collected 
from two different locations, namely Ghana (GH) and South Africa (SA). Out of these leaf 
extracts, two were selected, i.e., Vernonia amygdalina (VA) and Persea americana (PA). The 
aim of this study is to investigate the phytochemicals in four different solvents of extracts of 
COA® compared to leaf extracts of VA and PA collected from GH and SA by phytochemical 
screening techniques and Gas Chromatography-Mass Spectrometry (GC-MS).  
Outcomes of the preliminary phytochemical screening showed a positive result for alkaloids, 
anthraquinones, saponins, flavonoids, tannins, terpenoids as well as cardiac glucosides in 
ethanolic leaf extracts and standard COA®. GC-MS study was carried out in four solvents 
(dichloromethane, hexane, ethanol and ethyl acetate) and standard COA®. The finding, of this 
study, confirms the presence of VA and PA leaf extracts in COA®.  The major phytochemicals 
common to COA® extract and leaf extracts of VA and PA were heneicosane, phytyl acetate, 
pyrene, octadecanoic acid, eicosane, 2-methyltetracosane, pentadecanoic acid, 
hexadecanamide, and octadecanamide. Most of these major phytochemicals are present in 
ethanolic extracts of both COA® and leaf extracts of VA and PA. Leaf extracts of medicinal 
plants collected from Ghana have more phytochemicals compared to that of South Africa. The 
variation in phytoconstituents can be ascribed to the plants’ geographical area and 
environmental factors.   
Keywords: COA® herbal medicine; Vernonia amygdalina; Persea americana; 




The Africa continent is enormous, bestride by the equator and endowed with more than 50,000 
distinct known plant species in the sub-Saharan African region alone.1 The continent of Africa 
has lavish cultures and traditions, which are valuable and protected with pride and to preserve 
the cultural heritage in a swiftly changing society. Herbal medicine practices are parts of the 
traditions of the people on the African continent. Traditional African Medicine (TAM) is 
probably the oldest, and most assorted, of all traditional medicine systems (TMS).2 On the 
African continent, people have used or continue to use traditional medicines for the management 
or treatment of diseases in both humans and livestock. The most preferred part of medicinal 
plants for treatments in TAM is the young succulent, green and fresh leaves, although other 
parts such as the roots, stem, and flowers are used in TAM. Medicines made from the leaves of 
plants are largely water-based organic decoction extracts used as tonic drinks. 3,4  
Traditional preparations of the Vernonia amygdalina and Persea americana are decoctions and 
infusions of leaves, stems, twigs and/ or roots. Yeap et al. (2010) reported that V. amygdalina 
had a lot of health-promoting benefits for human use as well as the poultry industry.5.5 Root 
decoctions of P. americana have been reported to be used in treating diabetes in South Africa6. 
In Cameroon and Kenya, the management of diabetes makes use of leaf decoctions. 7,8. Leaf 
infusions of the same plant were used in treating diarrhea, hypertension and cough in the 
Democratic Republic of Congo9 as well as malaria in Ghana10, Ivory Coast11, and Nigeria12-14.  
The Centre of Awareness (COA), a non-governmental organization, based in Cape Coast, 
formulated the COA® (Centre of Awareness) herbal medicine, which contains Vernonia 
amygdalina (VA) (Bitter leaf), Persea americana (PA) (Avocado), Azadirachta indica Carica 
papaya. Spondias mombin and Ocimum viride (FDA/DRID/HMD/HMU/16/0981, 2016) 
amongst which VA and PA were used for the present study. The COA® has been ordered online 
by several patients as immune boosters against human immunodeficiency virus/Acquired 
Immune Deficiency Syndrome (HIV/AIDS) and as treatments in diabetes mellitus, cancer and 
high blood pressure (https://www.coadrugs.org).   
In spite of advancements in treating diseases with orthodox medicines, numerous African 
patients resort into the utilization of TM for basic health care.15,16 For decades, plants that make 
the composition of COA® have been used by local communities in Africa for the management 
of diseases.5,6 Numerous phytochemicals with potent bioactivities have been isolated from 
leaves of V. amygdalina including sesquiterpenes, edotides, flavonoids: luteolin-7-O-
glucuronide, luteolin 7-O-glucoside, and glycosides. 17, 18 Owolabi et al. (2005) isolated 
phytochemicals from leaf extracts of P. americana that yielded isorhamnetin, luteolin, rutin, 
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quercetin, and apigenin. Identified chemical compounds of V. amygdalina extracts, examined 
by gas chromatography-mass spectrometry (GC-MS) includes aliphatic acidic, esters, terpenes, 
diterpene alkanols and phytostanol in aqueous, methanol and petroleum ether extracts.19 Phytol 
was the principal diterpene alcohols in methanolic and petroleum ether extracts.20 Hydrocarbons 
(heneicosane, octadecane, eicosane, docosane, tricosane, tetracosane, and squalene), with 
sterols such as sitosterol and stigmasterol derivatives, were identified in fruit and seeds extracts 
of P. americana.21 P. americana is rich in βeta-sitosterol and  it decreases cholesterol.22 P. 
americana fruit extract contains vitamin E. Vitamin E is needed in the body to the maintenance 
of  an overall health.22  
Alkaloids are heterocyclic nitrogen compounds.  Morphine is an opiate alkaloid isolated from 
Papaver somniferum, whereas, the popular codeine and heroin are derivatives of morphine. 
Diterpene alkaloids have antimicrobial properties while other alkaloids might be valuable 
against HIV and intestinal contaminations related with to AIDS.23 Alkaloids have antidiarrheal 
effects. The antidiarrheal activity could be the effect of travel time in the small digestive tract. 
Berberine is an aromatic member of the alkaloids with a planar orientation that has antidiarrheal 
activity linked to its deoxyribonucleic acid (DNA) intercalating ability.23   
Due to diverse medicinal importance of the COA®, there is a need to identify different 
phytochemicals in both COA® and crude extracts of V. amygdalina and P. americana found in 
Cape Coast (Ghana) and Durban (South Africa) using phytochemical screening methods and 
GCMS analysis. It has been reported in the literature that V. amygdalina and P. americana 
contains tannins, polyphenols, flavonol, terpenoids, and alkaloids. Cowan et al.(1999), in a 
clinical microbiology reviews on plant products as antimicrobial agents, reported that it is 
advisable to use ethanol as a solvent to carry out the  preliminary phytochemical screening due 
to its nontoxicity, low evaporation temperature and also act as a preservative in   medicinal plant 
extracts suspected to contain tannins, polyphenols, flavonol (flavonoids), terpenoids and 
alkaloids. 23, 24   
The least complex bioactive phytochemicals are phenols and phenolic acids consisting of a 
phenolic ring. Polyphenols are largely effective against viruses, bacteria, and fungi. 23 A few 
authors suggested that phenolic toxicity is directly proportional to the sum total of hydroxyl 
groups present. Therefore, increased in the sum total of hydroxyl groups, increases the inhibitory 
properties of phenols. Flavonoids are hydroxylated derivatives of phenolic compounds and have 
antimicrobial properties. Polymeric phenolic compounds found in almost every part of 
medicinal plants are tannins. Tannins are antimicrobial and are derivatives of flavan through 
condensation polymerization of quinone units. Another important phytochemical whose 
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mechanism of action is not well explained is a class of compound with a general chemical 
structure of C10H16 called terpenes. Terpenes occur as hemiterpenes, sesquiterpenes, diterpenes, 
triterpenes, and tetraterpenes (n = ½, 1½, 2, 3, 4. where n = number of carbons in the general 
structure = C10 as C5, C15, C20, C30, and C40). 23 Terpenes that have oxygen and /or other elements 
as additional elements are known as terpenoids. Terpenoids are antibacterial, antifungal and 
antiviral and are largely synthesized from acetate units originating from fatty acids but differ 
from fatty acids due to the extensive branching and cyclization of the chains. 23  
The geographical area of the leaf extracts used in the preparation of the COA® may have 
differences and/or similarities in their phytochemicals responsible for the pharmacological 
activities of the COA®. The aim of this study is to investigate the phytochemicals in four 
different solvent extracts of COA® compared to leaf extracts of V. amygdalina and P. americana 
collected from Cape Coast (Ghana) and Durban (South Africa) by phytochemical screening 
techniques and gas chromatography-mass spectrometry (GC-MS) analysis.   
2. Experimental 
2.1. Collection of Plant Materials, Reagents and Instrumentations 
Twenty-four bottles of COA® (6000 mL) were purchased on the Durban market. Medicinal 
plants, V. amygdalina (bitter leaf) and P. americana (avocado) were collected from Pinetown                        
(coordinates:-29.8224146, 30.8453970), Port Shepstone ( coordinates:-30.7373037, 
30.4387322) Durban-South Coast in South Africa respectively (03/03/2018 at 10:30 Central 
African Time, average temperature of 22 °C, average, humidity of 79% and average pressure of 
1014 mbar).  Medicinal plants from Cape Coast (Coordinates: 5.114467,-1.287032) Central 
Region of Ghana were collected on 17/08/2018 at 10:30 am Central African Time with an 
average temperature of 25 °C, average humidity of 80% and the average pressure of 1009 mbar. 
The plants were identified and authenticated at the Herbarium in the School of Life Sciences, at 
University of KwaZulu-Natal - Westville Campus.  
All chemicals and solvents used in this research work were of analytical reagent grade (AR grade) 
and purchased from Sigma Aldrich and Merck Millipore, South Africa. Hexane and ethyl acetate 
were purchased from Associated Chemical Enterprises. Dichloromethane and ethanol were 
purchased from Sigma Aldrich, South Africa. Whatman filter paper was purchased from Sigma 
Aldrich, South Africa. Different instruments such as Rotary evaporator (Büchi-Germany), 





2.2.1. Study Design 
Experimental procedures in this research were carried out after the collection of materials in two 
phases, namely preliminary phytochemical screening and GC-MS analysis. Preliminary 
phytochemical screening was carried out using the methods as reported by Iqbal et al. (2015). 
GCMS analysis described by Alara et al. (2018) was used.25,26 These experiments were conducted 
on COA® extract and leaf extracts of V. amygdalina and P. americana collected from Cape Coast, 
Ghana (Coordinates:5.114467,-1.287032) and Durban, South Africa (coordinates:-30.7373037, 
30.4387322).  This study was conducted in the Medicinal Chemistry laboratory at the School of 
Pharmaceutical Sciences, UKZN, Westville and the Mass Spectrometry Laboratory, School of 
Chemistry, UKZN, Pietermaritzburg.  
2.2.2. Drying, Size Reduction and Extraction Procedure 
The fresh leaves of V. amygdalina (bitter leaf) and P. americana (Avocado) were cleaned from 
dirt and unwanted pathogens separately with distilled water. The leaves were air-dried, at room 
temperature and pulverized to a coarse-to-fine powder. Leaf powder (30g) was weighed using an 
analytical balance for each medicinal plant and placed in a 250 mL conical flask that was 
subsequently sealed. Serial exhaustive extraction method involving successive extractions with 
solvents of different polarities namely hexane, dichloromethane, ethyl acetate and ethanol at gas 
chromatography grade (GC grade) were used. Each leaf powder was successively extracted with 
250 mL solvent twice. A total volume of solvent used for each plant leaf powder was 500 mL. 
This was to ensure that a range of compounds with varying polarities was extracted.27 Each solvent 
extract was filtered using a Whatman filter paper, concentrated and dried using a rotary evaporator 
and preserved in the refrigerator for future use in phytochemical screening and GCMS.28   
2.2.3. Solvent (liquid-liquid) Extraction  
Non-volatile components of a liquid can be extracted using solvent extraction. 29 The COA® herbal 
medicine was prepared in an aqueous medium, by fermentation of all medicinal plant leaves and 
distilled by selective boiling and condensation. The COA® extract was partitioned between less 
polar (hexane, dichloromethane) and more polar (ethyl acetate, ethanol) organic solvents. This 
was to allow a considerable separation of the non-polar chemical constituents of COA® from the 
polar ones.  In terms of the more polar solvents used for extraction, ethanol was the preferred 
polar solvent to aqueous because water is too polar and will not extract non-polar substances. 
Although both methanol and ethanol are polar molecules, the high electronegative oxygen in 
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ethanol permits hydrogen bonding to take place with other molecules, thereby, attracting polar 
and ionic molecules. The non-polar property of the ethyl (C2H5) group in ethanol permits the 
attraction of non-polar molecules. Thereby, ethanol that is least toxic of the alcohols can attract 
both polar and non-polar molecules.30  
2.2.4. Phytochemical Screening 
For the successful determination of biologically active chemical components, there is a need for 
proper use of solvents in the extraction procedure. Ncube et al. (2008)31 suggested that some 
characteristics of a good solvent for plant extractions may include toxicity, rapid evaporation at 
low temperatures, promotion of increased physiologic absorption of the extract, preservative 
properties and the ability of solvent not to cause the extract to complex or dissociate.31   
Tests were carried out (in triplicates) according to standard procedures as reported by Iqbal et al. 
(2015) 25 and Sengar et al. (2015).32 Qualitative analysis to determine the presence of alkaloids, 
steroids, flavonoids, saponins, terpenoids/triterpenoids, tannins, anthraquinone derivatives, and 
cardiac glycosides were carried out following standard procedures on standard COA® herbal 
medicine and ethanolic leaf extracts of V. amygdalina and P. americana . One milliliter each of 
COA® herbal medicine and ethanolic leaf extracts of V. amygdalina and P. americana collected 
from Ghana and South Africa were measured into 5 different test tubes that were used as controls.  
2.2.4.1. Test for Saponins (Frothing test) 
One milliliter each of COA® herbal medicine extract and ethanolic leaf extract of V. amygdalina 
and P. americana (Ghana and South Africa) were taken into 10 different test tubes out of which 
5 test tubes act acted as controls. To each 1.0 mL of extract, 10 mL of distilled water was added. 
The mixture was agitated for 15 min. Formation of a layer of foam indicated the presence of 
saponins. 
2.2.4.2. Test for Tannins (Ferric chloride test) 
One milliliter each of standard COA® herbal medicine extract and ethanolic leaf extracts of 
Vernonia amygdalina and Persea americana were measured into 5 separate test tubes and 1 mL 
of ferric chloride (5% FeCl3 in 95% ethanol) was added and the mixture was shaken. Formation 






2.2.4.3. Test for Anthraquinones Derivatives (Borntrager’s test) 
One milliliter each of standard COA® herbal medicine extract and ethanolic leaf extracts of V. 
amygdalina and P. americana were measured into 5 different test tubes.  One milliliter of 32% 
ammonia was added with agitation for a few seconds. The appearance of pink-red color in the 
lower ammoniacal layer indicated the presence of anthracene derivative. 
2.2.4.4. Test for Cardiac Glycosides (Keller Killian test) 
The two-milliliter volume of Standard COA® extract and 2.0 mL ethanolic leaf extracts of V. 
amygdalina and P. americana were measured into 5 separate test tubes. To this 2.0 mL of 
chloroform, 1.0 mL acetic acid and 1.0 mL ferric chloride solution was added, Dropwise 1.0 mL 
concentrated H2SO4 was added on the inner walls of the test tube. Appearance of a brown ring at 
interphase with an upper green-blue coloration shows the presence of glycosides.   
2.2.4.5. Test for Alkaloids  
(a) Meyer Test 
Standard COA® extract of volume 1.0 mL and 1.0 mL ethanolic leaf extracts of V. amygdalina 
and P. americana (Ghana and South Africa) were measured into 5 different test tubes. To these 
test tubes, 2 mL of Meyer’s reagent was added and agitated slightly. Extracts in five other test 
tubes were used as controls. A light yellowish precipitate confirmed the presence of alkaloids. 
 (b)  Wagner Test 
To 1.0 mL each of standard COA® extract and ethanolic leaf extracts of V. amygdalina and P. 
americana were measured in 5 separate test tubes. Two milliliters of Wagner Reagent (1.271 g 
iodine + 2.001 g potassium iodide) was added and shaken. Formation of a brown precipitate 
indicated a positive result for alkaloids.  
 (c) Acid Tests (Litmus Paper) 
This was a confirmatory test for alkaloids in standard COA® herbal medicine extract as the Meyer 
test had very light yellowish precipitate. A Universal litmus paper was dipped in 1.0 mL standard 
COA® extract. The litmus paper showed acidity of the COA® extract. This confirms that the 
extract contains alkaloids.  
2.2.4.6. Test for Terpenoids (Liebermann-Burchard test) 
Standard COA® extract of volume 1.0 mL and 1.0 mL ethanolic leaf extracts of V. amygdalina 
and P. americana was measured into 5 separate test tubes. To these 3 drops of acetic anhydride 
were added. Dropwise, 1.0 mL concentrated H2SO4 were added dropped onto the inner walls of 
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the test tube slowly and the mixture left to stand for a few minutes. A brown ring at the interface 
and a green color indicated the presence of terpenoids.  
2.2.4.7. Test for Flavonoids (Sulfuric acid tests) 
To 1.0 mL of standard COA® extract and ethanolic leaf, extracts of V. amygdalina and P. 
americana were measured into five separate test tubes. 1.0 mL of concentrated H2SO4 was added 
and shaken vigorously. A deep yellowish to reddish color after a few minutes indicated the 
positive result of flavonoids.  
2.3. Characterization of the Various Phytochemicals in COA® Herbal Mixture and the Plant 
Leaf Extracts  
Gas chromatography-mass spectrometry (GC-MS) technique was used for the characterization of 
the various volatile and non-volatile compounds present in the solvent leaf extracts of V. 
amygdalina and P. americana.  
The chemical compound identification and retention times of V. amygdalina and P. americana 
leaf extracts from Cape Coast-Ghana and Durban- South Africa were evaluated using  GC-MS 
analysis. GC-MS analysis was conducted according to procedures as described by Alara et al. 
(2018). 26  
Approximately 30 g powder of each of V. amygdalina and P. americana were extracted 
successively for 6 hours per session with GC grade solvents of dichloromethane (DCM), ethanol 
(EtOH), hexane (HEX), and ethyl acetate (EtOAc) and filtered using Whatman filter paper. 
Standard COA®, COA® extract from the four different solvents and leaf extracts from the four 
different solvents of V. amygdalina and P. americana (Ghana and South Africa) extracts were 
concentrated using a Rotary evaporator. Each sample was loaded in GC-MS compatible vials and 
analyzed.  
Specifications: Analysis by GC–MS using Perkin (Emler) Gas Chromatography (Clarus 580) 
equipped with MSD mass spectrometer (Clarus SQ8S) instrument with the built-in auto sampler.  
Column: Elite-5MS (30 m x 0.25 mm id x 0.25 μm). The oven temperature programmed from 37 
to 320°C at a rate of 18-25°C/min and held for 0.5 and 1.85 mins at 18 and 320 °C respectively. 
The injector temperature: 250°C and MS Ion Source temperature: 280°C with full scan and 
solvent delay of 0–2.30 min. MS Scan Range was m/z 35 – 500 in 0.10 sec. One microlitre of the 




2.4. Data Analysis 
All the experimental analysis were carried out according to the standard experimental procedures 
to ensure the validity and accuracy of the experimental work. Results from GC-MS of the 
chemical compounds obtained were checked for duplications for phytochemical structures and 
/or names and contaminants from the GC-MS columns were identified and eliminated from the 
study. Data are categoried into similar and /or different phytochemical structures and /or names 
between COA® and leaf extracts of plants collected around Cape Coast-Ghana and Durban- South 
Africa. In addition to the identification of similar and /or different phytochemicals by compound 
names, retention time  of the phytochemicals were used in the analysis of similarities and /or 
differences between standard COA®, COA®  in the four solvents and leaf extracts in all four 
solvents of plants collected around Cape Coast-Ghana and Durban- South Africa.  
3. Results and Discussions 
3.1. Preliminary Phytochemical Screening of Ethanolic Leaf Extracts (V. amygdalina and P. 
americana) and standard COA® Herbal Medicine 
Phase one consisted of a qualitative chemical examination ( done in triplicate but since results 
were similar it is recorded as one) of different ethanolic extracts of V. amygdalina and P. 
americana to determine the presence of alkaloids, anthraquinone derivatives, saponins, 
flavonoids, tannins, terpenoids and cardiac glucosides as demonstrated in Table 1.   
In this investigation, the class of phytochemical detected in the ethanol leaf extracts of V. 
amygdalina and P. americana were alkaloids, anthraquinone derivatives, saponins, flavonoids, 
tannins, terpenoids, and cardiac glucosides. Result of phytochemical screening and insecticidal 
activity of ethanolic extracts of V. amygdalina revealed the presence of alkaloids, tannins, 
phlobatannins, flavonoids, terpenoids, cardiac glycosides, and saponins, which is in line with the 
results obtained in this investigation.33 Findings from fruit extract of P. americana indicated the 
presence of alkaloids, flavonoids, terpenoids, and cardiac glycosides but tannins and saponins 
were absent.34 An ethanolic leaf extract of P. americana in a study by Kumala et al. (2013) 







Table 1 Preliminary phytochemical screening of COA® herbal medicine extract and different 






















Meyer  +++ +++ +++ +++ +++ 
Wagner   +++ +++ +++ +++ +++ 
Acid tests NA NA NA NA +++ 
Anthraquinones  
Derivatives (n=3) 
Borntrager’s  +++ +++ +++ +++ +++ 
Saponins (n=3) Frothing  +++ +++ +++ +++ +++ 
Flavonoids (n=3) Sulfuric acid  +++ +++ +++ +++ +++ 




+++ +++ +++ +++ +++ 
Cardiac glucosides 
(n=3) 
Keller Killian +++ +++ +++ +++ +++ 
Legend: (+) present; (-) absent; (NA) not applicable, (n=3) experiment done in triplicate (+++) 
3.2 Gas Chromatographic and Mass Spectrometry (GC-MS) 
3.2.1 GC-MS analysis of COA® herbal medicine extract in DCM, Hex, EtOH, and 
EtOAc  
Phase two consisted of the identification and characterization of chemical compounds present in 
COA® herbal medicine (standard) extract and COA® extract using GC-MS analysis in DCM, Hex, 
EtOH, and EtOAc.   
Table 2 presents chemical compounds in extracts of COA® (standard) and in the four different 
solvents. The names of the compounds in the standard and the four solvents are presented with 
chemical compound presented by names, chemical formula and retention time. Among the four 
types of solvents used in this study and the standard COA®, COA® hexane extracts had 60 
chemical compounds, the highest, DCM at had 47, ethyl acetate had 37  ethanol at had 18 with 
COA® standard having the least number at 10 chemical compounds. Previously, Hashmi et al. 
(2013) also carried out the GC-MS analysis of different organic crude extracts from Thymus 
vulgaris L. and reported that hexane, as a solvent of extraction presented major chemical 
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compounds.  Hexane which is a non-polar solvent, extracted more chemical compounds COA® 
extract more than the other solvents of extraction..36   
The major active chemical constituents present are 2-methyltetracosane, Phytol acetate, 2,2'-
Methylenebis(6-tert-butyl-p-cresol), 11-decyl-Tetracosane, gamma-Sitosterol, Stigmasterol, 
Testosterone Valerate, 2(3H)-Furanone, Furyl hydroxymethyl ketone, 2H-Pyran-3-ol, 
Epiglobulol and Cholesta-4,6-dien-3-ol.37  
The various active constituents present in these extracts are responsible for different biological 
and pharmacological activities. For example 2-methyltetracosanehas been reported to have free 
radical scavenging activity38 while phytol acetate a derivative of phytol, has antimicrobial, 
antiinflammatory, anticancer and antidiuretic properties.39 Cantrell et al. (2001) reported  
antimycobacterial activity of phytol acetate against Mycobacterium tuberculosis, in vitro.40 
Phenol, 2,2'-methylenebis(6-tert-butyl-p-cresol) have been reported to have antimicrobial and 
anti oxidant effects.41 gamma –Sitosterol is a phytosterol present in plants, used in traditional 
medicines and have strong antifungal, antibacterial and anti-angiogenic activity.42 Previous 
studies have reported that stigmasterol  has a chemopreventive effect on 7,12-
dimethylbenz[a]anthracene (DMBA)induced skin cancer investigated in Swiss albino mice.43 
2(3H)-Furanone  has been reported to have antimicrobial activities against S. aureus, Bacillus 
subtilis E. coli and Pseudomonas aeuroginosa.44 Furyl hydroxymethyl ketone exhibits moderate 
inhibition against the two Gram-positive bacterial strains (S. aureus KCTC 209 and S. aureus 
KCTC 503).45 2(H)-Pyran-3-ol has been reported  to have  antibacterial and antifungal properties 
46 while  Lourens et al.( 2004), reported  antioxidant  activity against diphenyl-picrylhydrazine 
(DPPH assay), antimicrobial and anti-inflammatory activity on Helichrysum dasyanthum, 
Helichrysum, felinum, Helichrysum excisum and Helichrysum petiolare of Epiglobulol.47 
Cholesta-4,6-dien-3-ol is a steroid with antimicrobial and free radical scavenging activities.48   
The presence of various bioactive compounds present in different solvents system justifies the 




Table 2: Phytochemicals in dichloromethane (DCM), hexane, ethanol, and ethyl acetate extract of COA® herbal medicine and standard COA® herbal 
medicine 
 COA® Herbal Medicine 
 dichloromethane extract 
COA®  Herbal Medicine- 
Hexane extract   
COA®  Herbal Medicine- 
Ethanol extract 
COA®  Herbal Medicine 












Chemical Constituents Rt 
min 
Chemical Constituents Rt 
min 
1 2-Penten-1-ol 3.684 N,N-Dimethyl- 
formamide  
2.663 Triethylamine 2.53  Toluene 3.314 Carbonic acid, methyl pentyl 
ester 
2.99 




2.906  Spiro[2,4]hepta-4,6-diene 10.566 Dimethylsulfoxonium 
formylmethylide 
3.015 
3 4-Hexen-1-ol 4.797 3-hydroxy- 
Benzonitrile 
4.047 chloro-Benzene 3.099  Toluene 10.597 Acetic acid,  3.348 
4 (E)-2-Hexen-1-ol 4.883 Aniline 4.209 4-hydroxy-
Butanoic acid  
3.752  1,3-Octanediol 10.706 Acetic acid 3.419 
5 Formic acid hexyl ester 4.929 (E)-3-Hexenoic acid 4.268 isocyanato- 
Benzene 
4.088  Furfural 10.819 3-Hexen-1-ol 3.475 
6 Pentanoic acid 5.108 2H-Pyran-2, 6 (3H)-
dione  
4.324 Aniline 4.284 Chlorobenzene 11.304 Formic acid, hexyl ester 3.615 
7 3-Pentanol 5.176 (E)-2-Hexenoic acid 4.479 Phytol, acetate 10.59  Hexyl chloroformate 11.958 Hexanoic acid 4.579 





10.728 5-Methyl-2-furaldehyde 12.101 Heptanoic acid 4.645 
9 Ethanol, 2-butoxy- 5.367 1-Octadecyne 5.718 Pentadecanoic acid 11.297 2-Hexenoic acid 12.266 4-Octene 4.705 
10 Butanoic acid 5.471  Dodecane 6.106 Pyrene 12.108 α.-Calacorene 12.357 2-Hexenoic acid 4.818 
11 Cyclopentane 5.561 5-Methyl- tridecane 7.324 7-Tetradecenal 12.272  4,6-Heptadien-2-one 12.603 Methyl salicylate 6.232 
12 Heptan-2-yl acetate 5.645 Tetradecane 7.685 Octadecanoic acid 12.375 Di-epi-.alpha.-cedrene-(I) 12.99 NA NA 
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13 4-Methylhept-1-ene 5.956 4-Methyl- tetradecane 8.408 Hexadecanamide 12.5  1-Naphthalenol 13.339 NA NA 
14 2H-Pyran-2,6(3H)-dione 6.599 Butylated 
Hydroxytoluene 
8.48 9-Octadecenamide 13.4  2-Naphthalenemethanol 13.951 NA NA 
15 Hexanoic acid 6.787 5-methyl- tetradecane 8.765 Octadecanamide 13.506  Naphthalene 14.039 NA NA 
16 3-Hexenoic acid 6.946 Hexadecane 9.098 Diisooctyl 
phthalate 
14.15  Benzene 14.392 NA NA 
17 Methoxyethylamine 
Acrylo Nitryl 
7.037 8-Hexyl- pentadecane 9.646 Cholesta-4,6-dien-
3-ol 
16.543  9-Undecenal 14.818 NA NA 
18 Benzyl alcohol 7.194 3-Methyl-heptadecane  9.956 Stigmast-5-en-3-
ol, oleate 
16.642  Neoclovene oxide 14.862 NA NA 
19 2(3H)-Furanone 7.427 5-Methyl-tetradecane  10.062 NA NA 1-Cyclohexanone 15.185 NA NA 
20 2-Hexenoic acid 7.68 2-Methylhexadec-1-
ene 
10.157 NA NA 4-(2-Acetyl-5,5-
dimethylcyclopent-2-enyliden 
15.215 NA NA 
21 Furyl hydroxymethyl 
ketone 
7.824 Heptadecane 10.366 NA NA Pentafluoropropionic acid 15.304 NA NA 
22 α-Methyl-α-[4-methyl-3-
pentenyl]oxiranemethanol 
7.914 2-methyltetracosane 10.448 NA NA  2-Naphthalenemethanol 15.621 NA NA 
23 1-Cyclohexyl-2-
nitropropane-1,3-diol 
7.978 Phytyl acetate 10.59 NA NA  7-Oxocholesteryl isocaproate 15.72 NA NA 
24 Maltol 8.314 5-Methyl-tetradecane  10.949 NA NA (1S,2E,4S,5R,7E,11E)-
Cembra-2,7,11-trien-4,5-diol 
16.012 NA NA 
25 4-Butylcyclohexene 8.713  l-(+)-Ascorbic acid 
2,6-dihexadecanoate 
11.287 NA NA 3,3,5,5-Tetramethyl-4,5-
dihydro-3H-benzo[c] 
azepine,2-oxide 
16.205 NA NA 
26 2(H)-Pyran-3-ol 9.06 Methyl 2-Bromo-5-
methoxybenzoate 
11.637 NA NA  Phthalic acid 16.302 NA NA 
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27 Methyl salicylate 9.314 Trifluoroacetoxy 
hexadecane 
11.988 NA NA 4,6,10,10-Tetramethyl-5-
oxatricyclo[4.4.0.0(1,4)]dec-2-
en-7-ol 
16.45 NA NA 
28 Cyclopentan-1-al 9.655 Pyrene 12.102 NA NA 3-Heptyn-2-one 16.486 NA NA 
29 1-Methyl-3-butenyl 3-
methyl-3-hydroxybutyl  
9.75 (Z)-9-Octadecenal  12.281 NA NA  Pentadecanoic acid 16.546 NA NA 
30 2-Carene 9.79 Octadecanoic acid 12.366 NA NA Metolachlor 17.183 NA NA 
31 7-Octen-3-ol 10.26 Eicosane 12.564 NA NA 3-Buten-2-one 17.459 NA NA 
32 Pentadecane 10.531 2-Octyl-1-Dodecanol  12.599 NA NA  n-Nonadecanol-1 17.528 NA NA 
33 p-Ethoxybenzyl alcohol 10.76 Hexadecanoic acid 12.782 NA NA Tricyclo[3.3.1.1(3,7)]decane 17.594 NA NA 
34 2,2'-Bioxepane 10.89 8-Hexyl-pentadecane 12.874 NA NA Benzene 17.83 NA NA 
35 2,5-
Dimethyltetrahydrofuran 
11.089 2-methyltetracosane 12.957 NA NA  cis-9-Hexadecenal 18.216 NA NA 
36 1,5-Heptadien-4-ol 11.2 11-Decyl-tetracosane  13.056 NA NA Octadecanoic acid 18.402 NA NA 
37 Tetradecane 11.676 2,4-dimethyl-
Docosane,  
13.292 NA NA  1,4-Ethenoanthracene 18.477 NA NA 
38 2(4H)-Benzofuranone 13.257 Phenol 13.632 NA NA NA NA NA NA 
39 Z-5-Nonadecene 13.716 Trifluoroacetoxy 
hexadecane 
11.988 NA NA NA NA NA NA 
40 Epiglobulol 14.2 2-Methylhexacosane 13.983 NA NA NA NA NA NA 
41 1-Naphthalenol 14.548 2-Methyloctacosane 14.119 NA NA NA NA NA NA 
42 Oleyl alcohol, 
trifluoroacetate 













16.461 Tetratetracontane 14.834 NA NA NA NA NA NA 
45  Heneicosane 17.45 3,3,13,13-
Tetraethylpentadecane 
14.965 NA NA NA NA NA NA 
46 n-Tetracosanol-1 19.342 11-Decyl-tetracosane  15.042 NA NA NA NA NA NA 
47 n-Nonadecanol-1 21.846 1-iodo-Hexadecane  15.757 NA NA NA NA NA NA 
48 NA NA  Octadecyl 2-Propyl 
ester 
16.373 NA NA NA NA NA NA 
49 NA NA (3 beta)-Cholesta-4,6-
dien-3-ol  
16.54 NA NA NA NA NA NA 
50 NA NA 5-Methyl-Octadecane  16.692 NA NA NA NA NA NA 
51 NA NA 1-Bromo-2-methyl-
Decane  
17.353 NA NA NA NA NA NA 
52 NA NA Stigmasterol 17.481 NA NA NA NA NA NA 
53 NA NA 6,6-
Diethylhoctadecane 
17.657 NA NA NA NA NA NA 
54 NA NA gamma-Sitosterol 17.859 NA NA NA NA NA NA 
55 NA NA Silane 18.104 NA NA NA NA NA NA 
56 NA NA 1-bromo-Triacontane  18.333 NA NA NA NA NA NA 
57 NA NA Testosterone Valerate 18.473 NA NA NA NA NA NA 
58 NA NA Acetic acid 19.717 NA NA NA NA NA NA 
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59 NA NA Nonahexacontanoic 
acid 
22.207 NA NA NA NA NA NA 
60 NA NA octadecyl ester 
hexadecanoic acid 
23.233 NA NA NA NA NA NA 




3.2.2 GC-MS analysis of COA® herbal medicine extract and V. amygdalina and P. americana 
(Ghana and South Africa) in DCM 
The GC-MS analysis was carried out to identify the components present in the solvent extracts of 
COA® herbal medicine and the plant species V. amygdalina and P. americana.  
Table 3 presents comparative similarity studies of phytochemical compounds in COA® extract 
and V. amygdalina and P. americana (Ghana and South Africa) in DCM. Results showed that out 
of 50 compounds detected in the GC-MS only Heneicosane is present in both COA® and leaf 
extract of P. americana of Ghana although retention time is different which may suggest that the 
two are different compounds but the compound is of interest to find similarity. The variation in 
chemical constituent may be because of diversity in the geographical location.  
Falco et al. (2013) reported the presence of heneicosane as an essential oil in Persea americana 
(Avocado) Ghana. It indicated antimicrobial activities against numerous gram-positive pathogens 
and specifically Bacillus cereus and B. subtilis. The topographical area with the distinctive 
atmosphere condition showed a critical effect on the compound constituents of the plants.49 Şanli 
et al., 2017 detailed that few sections of the plant have essential oils in various amount, that can 
be affected by environmental conditions, such as altitude. Essential oil contents of avocado fruits 
are increased due to increasing altitude level.50 Hence, the geographical area of the plant must be 
considered in relation to the intended use.  
Table 3: Comparative similarity studies of phytochemical compounds in COA® herbal medicine 
extract and V. amygdalina and P. americana (Ghana and South Africa) in DCM  
S. 
No. 







(GH) EXTRACT  
Persea americana 






Rtmin Status Rt min Status Rt min Status Rt min Status 
1  Heneicosane C21H44 17.45 - - - - 16.21 + - - 








3.2.3. GC-MS Analysis of COA® Extract and Leaf Extracts of V. amygdalina and P. 
americana in Hexane from Ghana and South Africa 
Table 4 presents the comparative similarity study of phytochemical compounds in COA® extract 
and leaf extracts of V. amygdalina and P. americana in hexane from Ghana and South Africa. 
Phytyl acetate is present in both P. americana (GH) and V. amygdalina (GH) of Ghana and V. 
amygdalina (SA) of South Africa and COA® extract with Rt values ranging between 10.56-10.96 
but not in P. americana (SA). Pyrene is present only in P. americana (SA) hexane extract with 
an Rt value of 12.11.  Octadecanoic acid is the only chemical compound present in all the leaf 
extracts collected from two different locations and COA® extract. It has almost the same Rt value 
i.e. 12.35-12.26. It is a fatty acid ester having antioxidant activity51 and an antihypertensive agent. 
In P. americana (SA) leaf extracts eicosane was found with Rt value 13.05. Eicosane has wound 
healing, antimicrobial and anti-inflammatory properties.52 A compound, 2-methyltetracosane is 
present in leaf extracts of V. amygdalina (SA) with 16.03 and a free radical scavenging agent.38 
From the results the major chemical compound similar to the COA® extract and leaf extracts from 
both countries are octadecanoic acid and phytol acetate. There is a lack of phytol acetate in V. 
amygdalina (SA) leaf extract. This variation in chemical constituent suggests the diversity in 
biotic and abiotic factors in both countries such as geographical location, environmental 
conditions, and seasonal variation.  
Table 4:  Comparative similarity studies of phytochemical compounds in COA® herbal medicine 
extract and V. amygdalina and P. americana (Ghana and South Africa) in Hexane. 
Legend: (+) present; (-) absent. 
S. 
No. 

























Status Rt min Stat
us 
Rt min Status 




C25H52 12.95 - - 16.03 + - - - - 
3 Pyrene C16H10 12.10 - - - - - - 12.11 + 
4 Octadecanoic 
acid 
C17H35CO2H 12.36 12.36 + 12.38 + 12.35 + 12.35 + 
5 Eicosane C20H42 12.56 - - - - - - 13.05 + 
81 
 
3.2.4. GC-MS Analysis of COA® Extract and Leaf Extracts of V. amygdalina and P. 
americana in Ethanol from Ghana and South Africa 
Table 5 presents comparative similarity studies of phytochemical compounds in COA® extract 
and V. amygdalina and P. americana (Ghana and South Africa) in ethanol.  Chloro-benzene with 
Rt value of 3.11 is only present in leaf extract of P. americana (SA). Phytol acetate and 
pentadecanoic acid are present in COA® and leaf extracts of the two plants with Rt value of 10.57-
10.58 and 11.28-11.38. However, in leaf extracts of V. amygdalina (SA) and P. americana (SA), 
Hexadecanamide and octadecanamide are present with Rt value of 12.47-12.50 and 13.49.  
Hexadecanamide has been reported to have cytotoxic effect against a human colon 
adenocarcinoma cell line (HCT-116).53 On the other hand octadecanamide can be used a 
biomarker for hyperlipidemic conditions.54   
Table 5: Comparative similarity studies of phytochemical compounds in COA®herbal medicine 
extract and V. amygdalina and P. americana (Ghana and South Africa) in ethanol.  
 
































Status Rt min Status Rt 
min 
Status 
1 Chloro-Benzene C6H5Cl 3.09 - - - - - - 3.11 + 
2 Phytol acetate C22H42O2 10.59 10.57 + 10.58 + 10.57 + 10.58 + 
3 Pentadecanoic 
acid 
C15H30O2 11.29 11.32 + 11.28 + 11.30 + 11.28 + 
4 Hexadecanamide C16H33NO 12.5 - - 12.47 + - - 12.47 + 




3.2.5 GC-MS Analysis of COA® Extract and Leaf Extracts of V. amygdalina and P. 
americana in Ethyl Acetate from Ghana and South Africa 
Table 6 present comparative similarity studies of phytochemical compounds in COA® extract 
and V. amygdalina and P. americana (Ghana and South Africa) in ethyl acetate. Octadecanoic 
acid is present in all the leaf extracts collected from two different locations and COA® extract 
with an Rt value of 12.35 to 12.37. Toluene is present in V. amygdalina (SA) with Rt value of 
2.60.   Toluene is a pollutant in the environment due to its use in a wide variety of household and 
commercial products (largely from motor vehicle exhausts). 55 It has antipunishment property and 
acute and chronic effects on the central nervous system and may cause congenital anomalies in 
humans.56 In an investigation on phytochemical and pharmacological properties of n-hexane leaf 
extracts of Nymphoides indica, octadecanoic acid (stearic acid) including hexadecanoic acid was 
isolated with mild antimicrobial activity.57  
 
Table 6: Comparative similarity studies of phytochemical compounds in COA® herbal medicine 
extract and V. amygdalina and P. americana (Ghana and South Africa) in ethyl acetate. 
 


























1  Toluene C7H8 2.55 - - 2.60 + - - - - 
2 Octadecanoic 
acid 
C18H36O2 12.36 12.35 + 12.37 + 12.35 + 12.35 + 










3.2.6 GC-MS Analysis of Leaf Extracts of V. amygdalina in DCM, Hexane, Ethanol and 
Ethyl Acetate from Ghana and South Africa 
Table 7 presents similar and different chemical compounds in DCM, hexane, ethanol and ethyl 
acetate leaf extracts of V. amygdalina (Ghana and South Africa). The outcomes from the four 
solvents used in this study yielded 180 chemical compounds: 94 chemical compounds (52.22%) 
were available in VA (Ghana) only, 45 chemical compounds (25%) were available in VA (South 
Africa) only and 41 chemical compounds (22.78%) occurred in both VA (Ghana and South 
Africa).  These findings may suggest that geographical location and climatic conditions may 
influence the chemical composition of medicinal plants. One author observed that there was a 
substantial deviation in the amounts of phenolic compounds and protein-binding capacity of leaf 
extracts of Achyranthes aspera collected from Ciaat, Eritrea and Ukulinga, South Africa. A. 
aspera leaf extracts have antibacterial, antifungal, anthelmintic properties as compared to similar 
extracts from Ukulinga in South Africa.58 Another investigation revealed that the choice of 





Table 7: Comparative study of similar and different chemical compounds in DCM, hexane, ethanol and ethyl acetate leaf extracts of V. amygdalina 
(Ghana and South Africa). )  
 COMPOUND NAME VA(GH) VA(SA) VA(GH) 
 
VA(SA) VA(GH) VA(SA) VA(GH) VA(SA) 





















 STATUS STATUS STATUS STATUS STATUS STATUS STATUS STATUS 
1 α.-Amyrin + - + - + - + - 
2 γ.-Tocopherol + + + + + - + - 
3 12-Methyl-E,E-2,13-octadecadien-1-ol + - - - - - - - 
4 13-Docosenamide + + - + - + - - 
5 (22Z)-cholesta-5,7,22-trien-3-ol + - - - + - - - 
6 1-Heneicosanol + - + - + - + - 
7 2-(8-Chloro-3,7-dimethyl-octa-2,6-
dienyloxy)tetrahydropyran 
+ - - - + - + - 
8 2-Nonadecanone + + + - - - - - 
9 Hexadecanal + + + - + - - - 
10 Phytol + - + + + + + + 
11 Phytol  acetate + + + + + + + + 
12 3,7,11,15-Tetramethyl-2-hexadecen-1-ol + + + + + + + - 
13 Heptadecanal + - + - - - - - 
14 Pentadecanoic acid + + + + + + + + 
15 9-Octadecen-1-ol + + + - + - + + 
16 Octadecanoic acid + + + + + - + - 
17 9,12,15-Octadecatrienoic acid + - + - + - - - 






+ - + - + - - - 
20 Tetratetracontane + + + - - - + + 
21 2-Pentadecanone - + + - - + + + 
22 Hexadecanoic acid + - + - + - + - 
23 Chondrillasterol + - + - + - + - 
24 Ergosterol - - + - - - + - 
25 Cyclopropanemethanol + - + - - - - - 
26 Diisooctyl phthalate + - + - - - - - 
27 E,E,Z-1,3,12-Nonadecatriene-5,14-diol + - + - + - - - 
28 Squalene + - + + + - + - 
29 n-Tetracosanol-1 - + - - + - + + 
30  Stigmasterol + - - - + - + + 
31 Vitamin E + - + - + - + - 
32 Tetradecanoic acid + - + - + - - - 
33  Eicosanoic acid + - + - + - + - 
34 Oxirane + - + - - - + - 
35 9-Octadecenamide - - + - + + + + 
36 n-Nonadecanol-1 - - + - - - + - 
37  E-10,13,13-Trimethyl-11-tetradecen-1-ol 
acetate 
+ - + - - - - - 
38 Ergost-5-en-3-ol + - - - + - - - 
39 1,6,10,14,18,22-Tetracosahexaen-3-ol - - + - + - - - 
40 γ-Tocopherol - + + + + - + - 
41 9,12-Octadecadienoic acid (Z,Z)- - - + - + - - + 
42 Preg-4-en-3-one + - - - + - + - 
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43 dl-.alpha.-Tocopherol - - + - - - + - 
44 Benzene, chloro- - - - + - - + + 
45 1-Hexacosene - + - -  + + + 
46  cis,cis,cis-7,10,13-Hexadecatrienal - - - - + - - + 
47 Hexadecanamide - - - - - + - + 
48 Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate + + - - - - - + 
49 Octadecanamide -  - - - + - + 
50 11,13-Dimethyl-12-tetradecen-1-ol acetate + + - - - - - - 
51 2-methyltetracosane - + - + - + - - 
52 2-methyloctacosane + + - - - - - - 
53 Stigmast-5-en-3-ol, oleate + + - + - - - - 
54 Heneicosane +  - - - - - + 
55 γ.-Sitosterol - + - + - - - + 
56 Oxirane - + - - - - + - 
57 2-methylhexacosane - + - - - - + - 
58 8-Methylenecyclooctene-3,4-diol - - - - - - + - 
59  1-Phenanthrenemethanol - - - - - - + - 
60 o-Xylene - - - - - - + - 
61   (.+/-.)-Lavandulol, chlorodifluoroacetate - - - - - - + - 
62 Undecane - + - - - - - - 
63 2-Hexadecene - + - - - - - - 
64 Eicosyl heptafluorobutyrate - + - - - - - - 
65 Tetracosyl trifluoroacetate - + - - - - - - 
66 Tetracosyl acetate - + - - - - - - 
67 1,19-Eicosadiene - + - - - - - - 
68 1-Octadecanol - + - - - - - - 
69 Triacontyl trifluoroacetate - + - - - - - - 
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70 Oxirane - - - + - - -  
71 16-Hentriacontanone - - - - - - - + 
72 2-Tert-Butyl-5-(dimethoxy-phosphoryl)-3-
methyl-4-oxoimidazolidine-1-caboxylic acid 
- - - + - - - - 
73 3.alpha.,7.beta.-Dihydroxy-5.beta - - - - - - - + 
74 Cholesta-4,6-dien-3-ol - - - + - - - - 
75 10-Methyl-E-11-tridece-1-ol acetate - - - - - - - + 
76 Geranyl acetate - - - - - - - + 





- - - + - - - - 
79  Hexatriacontane - - - + - - - - 
80 Pyrene - - - + - - - - 
81 9-(3,3-Dimethyloxiran-2-yl)-2,7-
dimethylnona-2,6-dien-1-ol 
- - - + - - - - 
82 cis-9-Hexadecenals - - - + - - - - 
83 Sulfurous acid, 2-propyl tridecyl ester - - - + - - - - 
84 Cyclopentanone - - - - - + - - 
85 2-Ethylnon-1-en-3-ol - + - - - - - - 
86 Bis(tridecyl) phthalate - - - + - - - - 
87 Formamide - - - - - - + - 
88 Pentanoic acid, 4-hexadecyl ester - - - - - + - - 
89 γ.-Dodecalactone - - - - - + - - 
90 Eicosane - - - + - - - - 
91 1,1':3',1''-Tercyclopentane - - - - - + - - 
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92 Isosteviol - - - + - - - - 
93 13-Octadecenal - + - - - - - - 
94 1,2-Epoxynonane - - - + - - - - 
95 Silane - - - - - - - + 
96 cis-9-Hexadecenoic acid, trimethylsilyl ester - - - - - - - + 
97 Pentadecanal- - + - - - - - - 
98 Ergosta-7,22-dien-3-ol - - - - - + - - 
99 11-Dodecyn-1-ol acetate - - - - - - - + 
100 Cyclopropa[5,6]stigmast-22-en-3-ol - - - + - - - - 
101 2,3,4-Trimethyl-5-hexen-3-ol - - -  - - - + 
102 3-methyl-4-[(trimethylsilyl)oxy] - - - + - - - - 
103 Tetradecanamide - + -  - - - - 
104 Octadecane - - - + - - - - 
105 d-Glucitol, 2,5-anhydro-1-O-octyl- + - - + - - - - 
106 9-Octadecenoic acid + - - - - - - - 
107 Tetracosyl pentafluoropropionate + - - - - - - - 
108 Hexadeca-2,6,10,14-tetraen-1-ol + - - - - - - - 
109 Acetic acid + - - - - - - - 
110 Docosyl trifluoroacetate + - - - - - - - 
111 Methanesulfonic acid + - - - - - - - 
112 Methyl 12-oxo-9-dodecenoate + - - - - - - - 
113 1-Octadecanesulphonyl chloride + - - - - - - - 
114 2,2,4-Trimethyl-3-(3,8,12,16-tetramethyl-
heptadeca-3,7,11,15-tetraenyl)-cyclohexanol 
+ - - - - - - - 
115 2,6,8-Trimethylbicyclo[4.2.0]oct-2-ene-1,8-
diol 
+ - - - - - - - 
116 3,4-Dimethyl-2-pentanone + - - - - - - - 
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117 Cholest-22-ene-21-ol - - + - - - - - 
118 γ.-Ergostenol - - + - - - - - 
119  9,19-Cyclolanost-23-ene-3,25-diol - - + - - - - - 
120 2,6,10,14,18-Pentamethyl-2,6,10,14,18-
eicosapentaene 
- - + - - - - - 
121 1-Hexadecanol - - + - - - - - 
122  Hexadecanoic acid, octadecyl ester - - + - - - - - 
123 Lup-20(29)-en-3-ol, acetate - - + - - - - - 
124 Hexadecanoic acid - - + - - - - - 
125 Lanosterol - - + - - - - - 
126 11,13-Dimethyl-12-tetradecen-1-ol acetate - - + - - - - - 
127 2,3-Butanediol - - - - + - - - 
128 Octanoic acid - - - - + - - - 
129 9-Octadecenal - - - - + - - - 
130 2-Hexadecene - - - - + - - - 
131  Bicyclo[6.1.0]nonane - - - - + - - - 
132 d-Glycero-d-tallo-heptose - - - - + - - - 
133 D-Allose - - - - + - - - 
134 Docosanoic acid - - - - + - - - 
135  (E,E,E)-3,7,11,15-Tetramethylhexadeca-
1,3,6,10,14-pentaene 
- - - - + - - - 
136 Valeric acid - - - - + - - - 
137 Phosphoric acid, diethyl octyl ester - - - - + - - - 
138  Butyrolactone - - - - + - - - 
139  Hexadecane - - - - + - - - 
140 β.-d-Ribopyranoside - - - - + - - - 
141 Hexadecane - - - - + - - - 
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142 2-Hexadecene - - - - + - - - 
143 1-Hexadecen-3-ol - - - - + - - - 
144 Methanol - - - - + - - - 
145 2,3-Butanediol - - - - + - - - 
146 3-Eicosene - - - - + - - - 
147 Megastigmatrienone - - - - + - - - 
148 Pentalene, octahydro-2-[(2-octyl)decyl]- - - - - + - - - 
149 2-Dodecylcyclobutanone - - - - + - - - 
150 Cyclohexane - - - - + - - - 
160  3H-Naphtho[2,3-b]furan-2-one - - - - + - - - 
161 (E,E,E)-3,7,11,15-Tetramethylhexadeca-
1,3,6,10,14-pentaene 
- - - - + - - - 
162  Lycoxanthin - - - - + - - - 
163  15,17,19,21-Hexatriacontatetrayne - - - - + - - - 
164 beta.-D-Glucopyranose - - - - + - - - 
165 Stigmasta-4,7,22-trien-3.alpha.-ol - - - - + - - - 
166 Cholest-7-en-3-ol - - - - + - - - 
167 5,8,11-Eicosatriynoic acid, methyl ester - - - - + - - - 
168 10,12,14-Nonacosatriynoic acid - - - - + - - - 
169 2,3-Hexanedione - - - - + - - - 
170 Dodecanoic acid - - - - + - - - 
171 cis-13,16-Docasadienoic acid - - - - + - - - 
172  (E)-1-(2,3,6-trimethylphenyl)buta-1,3-diene  - - - - + - - - 
173 trans-2-[2'-(2''-Methyl-1''-
propenyl)cyclopropyl]propan-2-ol 
- - - - + - - - 
174 Pentane - - - - + - - - 
175 Benzeneacetic acid - - - - + - - - 
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176 Methoxyacetic acid, 2-pentyl ester - - - - + - - - 
177  Erythritol - - - - + - - - 
178 5-Isopropyl-6-methyl-hepta-3,5-dien-2-ol - - - - + - - - 
179 1,6,10,14-Hexadecatetraen-3-ol - - - - + - - - 
180 3-Hexanol - - - - + - - - 
Compound occur in Ghana (VA) only          Compound occur in both Ghana and South Africa (VA)         Compound present in South Africa (VA) only 
 








3.2.7 GC-MS analysis of leaf extracts of P. americana in DCM, hexane, ethanol and ethyl 
acetate from Ghana and South Africa 
Table 8 presents the comparative study of similar and different chemical compounds in DCM, 
hexane, ethanol and ethyl acetate leaf extracts of P. americana (Ghana and South Africa)  
  
Table 8 presents’ similar and different chemical compounds in DCM, hexane, ethanol and ethyl 
acetate leaf extracts of P. americana (Ghana and South Africa). The outcomes from the four 
solvents used in this study yielded 167 compounds: 61 compounds (36.53%) were present in PA 
(Ghana) only, 52 compounds (31.13%) were only present in PA (South Africa) and 54 compounds 
(32.34%) occurred in both PA (Ghana and South Africa).   These findings may suggest the effect 
of geographical location and climatic conditions on the presence and amount of phytochemicals. 
The outcome of this investigation is not in line with results reported by Shah 2015 on the 
phytochemical analysis of plants that have medicinal properties in mountainous areas around 
Mandi Bahauddin, Pakistan that there is no difference in plants due to their different environment, 
rather differences in species.60
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Table 8: Comparative study of similar and different chemical compounds in ethanol leaf extracts of P. americana (Ghana –PA (GH) and South Africa-
PA (SA)( n = 167, n represents the total number of chemical compounds identified inclusive of the repeated compound)
S/No. CCOMPOUND NAME PA (GH) PA (SA) PA (GH) 
 




















STATUS STATUS STATUS STATUS STATUS STATUS STATUS STATUS 
1 Bicyclo[3.1.0]hexane + - - - - - + - 
2 Eicosane - - - + - + - - 
3  1,2,3-Propanetriol, 1-acetate - + -  - - - + 
4  Cubedol - + + + - - + - 
5  4-epi-cubedol - - - - + - - - 
6  α.-Cubebene + - + - - - + - 
7  α .-Copaene - + + - - - + - 
8  Phytolacetate + + + * + + + + 
9  Caryophyllene + + + - + - + + 
10  Caryophyllene oxide - + + + - - + - 
11  β.-copaene + - + - - - + - 
12  2-Pentadecanone - + - + - + - - 
13  1-Hexacosene - + - - - + - - 
14  Humulene + - + - - - + - 
15  Pentadecanoic acid + + + + + + + + 
16  1,6-Cyclodecadiene + - + - + - + - 
17  Aromandendrene - - + - - - + - 
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18  Phytol + + + + + + + + 
19  3,7,11,15-Tetramethyl-2-hexadecen-1-ol + + + + + - + + 
20  9,12-Octadecadienoic acid (Z,Z)- - - - - + + - - 
21  Heptadecanal + - + - - - + - 
22  γ.-Elemene - - + - - - + - 
23  cis,cis,cis-7,10,13-Hexadecatrienal - -  - - + + - 
24  9-Octadecen-1-ol + + + - + - + + 
25  2-Hexadecene + - + - + - + - 
26  Octadecanoic acid + - + + + + + + 
27  Hexadecanamide - - - + - + - - 
28  7-Tetradecenal + + - - - - - + 
29  1,5-Cyclodecadiene - - + - - - + - 
30  (-)-Spathulenol - - + - - - + - 
31  7-Octen-3-ol - + + + + + + + 
32  Stigmasterol + + - + + + + + 
33  γ.-Sitosterol + + + + + + + + 
34  13-Docosenamide - + + - + - + - 
35  Heneicosane + - - - - + - - 
36  Stigmastanol - - + - + - + - 
37  Vitamin E + + + - + - + + 
38  9,17-Octadecadienal + + + -  - + - 
39  10-Methyl-E-11-tridece-1-ol acetate - - - + + + + + 
40  cis-9-Hexadecenoic acid, trimethylsilyl 
ester 
+ + + + - + - + 
41  Di(1-decynyl)mercury + + + - + - + + 
42  Tetradecanoic acid - - + - + - + - 
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43  11-Dodecyn-1-ol acetate + + + + + + + + 
44  3,7,11,Trimethyl-8,10- 
dodecedienylacetate 
- - - - + - + - 
45  Oxirane - + - + - - - - 
46  6,11-Undecadiene + - - - + - - - 
47  2,3,4-Trimethyl-5-hexen-3-ol + - - - - + - - 
48  2-Hydroxy-(Z)9-pentadecenyl propanoate + + + - + - + + 
49  11,14-Eicosadienoic acid, methyl ester + + - - - - - - 
50  Cyclohexane - - + - - - + - 
51  9-Octadecenamide - - - + - - - - 
52  (R)-(-)-14-Methyl-8-hexadecyn-1-ol + - + - - - - + 
53  1-Heneicosanol - + - - + - - - 
54  Tetratetracontane + + + + - + + + 
55  2-Nonadecanone, O-methyloxime - + - - + - - + 
56  Cyclopropaneoctanoic acid - - + - + - - - 
57  Cyclopropanecarboxylic acid, pentadecyl 
ester 
+ + - - - - - + 
58  E-11-Methyl-12-tetradecen-1-ol acetate + + - - - -- - + 
59  16-Hentriacontanone + + + + - + + - 
60  Acetic acid, 3-ethylpent-3-yl ester - +   - - - + 
61  Z-(13,14-Epoxy)tetradec-11-en-1-ol  
acetate 
+ + + + + - + + 
62  3-Methyl-1-dodecyn-3-ol - - + - + - + + 
63  Hexadecanal + + + + - - + + 
64  3-Methyl-2-(2-methylene-cyclohexyl)-
butan-2-ol 
- + - + - - - + 
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65  3-Isopropyl-4-methyl-dec-1-en-4-ol + + + - - - - - 
66  Estran-3-one + - + - - - + - 
67  (2-Methyl-[1,3]dioxolan-2-yl)-acetic  acid - - - - + - - + 
68  γ- Tocopherol + - + + + - + + 
69  9-Methyl-10,12-hexadecadien-1-ol acetate + + + - + - + + 
70  Z-5,17-Octadecadien-1-ol acetate - + + - - - - + 
71  Ethanol + + + - + - + + 
72  1-Heptacosanol + + + + - - + + 
73  9-Methyl-Z,Z-10,12-hexadecadien-1-ol 
acetate 
+ + - - - - - - 
74  Octacosyl acetate - + - + - - + + 
75  Ergost-5-en-3-ol + + + + + - + + 
76  9-Eicosyne - + - - - - + - 
77  Heptacosyl acetate + + - - - - - + 
78  Docosyl trifluoroacetate + - + - - - + - 
79  9,19-Cyclolanost-23-ene-3,25-diol - - - + + - + - 
80  9,19-Cyclolanostan-3-ol - - + + - - - + 
81  Oleic acid, 3-(octadecyloxy)propyl ester - + - - - - + + 
82  Tetracosyl acetate - - + - - - + - 
83  α.-Tocopherol - - + - + - + + 
84  17-Pentatriacontene + - + - + - - - 
85  2,3-Butanediol - - - - + - - - 
86  β.-Pinene + - - - - - - - 
87  2-Pentanol - - + - - - - - 
88  2-Propenoic acid, oxiranylmethyl ester - - - - + - - - 
89  Formamide - - - - - + - - 
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90  Benzene - - - - - - + - 
91  2(4H)-Benzofuranone - - - + - - - - 
92  Benzene, chloro- - - - - - + - - 
93  Pentanoic acid, ethyl ester - - - - - - + - 
94  4-Penten-2-one - + - - - - - - 
95  1H-Cycloprop[e]azulen-7-ol - - - + - - - - 
96  Ethyl orthoformate - - - - + - - - 
97  1-Heptanol - - - - - - + - 
98  1,6,10-Dodecatrien-3-ol - - - - - - - + 
99  1H-
Cyclopenta[1,3]cyclopropa[1,2]benzene 
- + - - - - - - 
100  1H-Cycloprop[e]azulene - - - + - - - - 
101  (3-Methyl-oxiran-2-yl)-methanol - - - - + - - - 
102  Eicosanoic acid - - - + - - - - 
103  4H-Pyran-4-one - - - - + - - - 
104  2-Butanone - + - - - - - - 
105  Isosorbide - - - - + - - - 
106  Cyclohexane + - - - - - - - 
107  Bicyclo[7.2.0]undec-4-ene - + - - - - - - 
108  6-Methyl-6-(5-methylfuran-2-yl)heptan-2-
one 
- - - - + - - - 
109  6,11-Dimethyl-2,6,10-dodecatrien-1-ol - - - + - - - - 
110  Tetracyclo[6.3.2.0(2,5).0(1,8)]tridecan-9-
ol 
- + - - - - - - 
111  2-Piperidinone - + - - - - - - 
112  n-Tetracosanol-1 - - - - - + - - 
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113  2-methylhexacosane + - - - - - - - 
114  2-methyloctacosane - - + - - - - - 
115  Squalene - - - - - - - + 
116  Z,Z-8,10-Hexadecadien-1-ol - - - + - - -  
117  2-Hexanone - - - - + - - - 
118  Silane - - - - - + - - 
119  7-Oxabicyclo[4.1.0]heptane - + - - - - - - 
120  1,3-Benzenediol - - - - + - - - 
121  3-Buten-2-one - + - - - - - - 
122  Z,Z-5,16-Octadecadien-1-ol acetate - - - - - - - + 
123  8-Hexadecanol + - - - - - - - 
124  30-Norlupan-28-oic acid - - - + - - - - 
125  5-Isopropyl-6-methyl-hepta-3,5-dien-2-ol - - - - + _ - - 
126  Octadecanamide - - - - - + - - 
127  Kauran-18-al,  - - - + - - - - 
128  n-Nonadecanol-1 + - - - - - - - 
129  1-Heptanol - - - + - - - + 
130  Geranyl acetate - - - - - + - - 
131  α.-Tocopheryl acetate - - - + - - - - 
132  2-Ethylnon-1-en-3-ol - + - - - - - - 
133  Tetradecyl trifluoroacetate - - + - - - - - 
134  3-alpha.,7.beta.-Dihydroxy-5.beta-
cholestanate 
- - - - - + - - 
135  cis-4,7,10,13,16,19-Docosahexaenoic  acid - - - + - - - - 
136  Silane - + - - - - - - 
137  2-Octylcyclopropene-1-heptanol - - - + - - - - 
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138  n-Heptadecanol-1 - - - - - - + - 
139  cis, 6-Octadecenoic acid, trimethylsilyl 
ester 
- + - - - - - - 
140  Decalin-8a-ol-7-one - + - - - - - - 
141  Cyclopropanecarboxylic acid - - - - + - - - 
142  5-Hexadecanol - + - - - - - - 
143  Cholest-4-en-3-one - - + - - - - - 
144  α.-Tocopherol-.beta.-D-mannoside - - - - - - + - 
145  Oxirane - - - + - - - - 
146  Z,Z-4,6-Nonadecadien-1-ol acetate - - - - + - - - 
147  Tetracosanal - - - - - - - + 
148  2-Isopropenyl-5-methylhex-4-enal - - - - - - + - 
149  1,2-15,16-Diepoxyhexadecane - - + - - - - - 
150  10,11-Epoxy-n-undecan-1-ol - - - - - - + - 
151  Oxirane - - + - - - - - 
152  1,3-Dioxolane - - + - - - - - 
153  Cyclopropanecarboxylic acid - - - - - - + - 
154  Stigmast-4-en-3-one - - - + - - - - 
155  2,4-Hexadienedioic acid -  - - + - - - 
156  Tetracosyl trifluoroacetate - + - - - - - - 
157  4,22-Stigmastadiene-3-one - - - - - - - + 
158  Tetracosane - - + - - - - - 
159  Stigmastane-3,6-dione - - - + - - - - 
160  Eicosyl pentafluoropropionate - - - - + - - - 
161  Tetracosyl pentafluoropropionate - - - - - - - + 
162  Heptacosyl trifluoroacetate + - - - - - - - 
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163  13,15-Octacosadiyne - - - - - - - + 
164  6,10,14-Trimethyl-pentadecan-2-ol - - + - - - - - 
165  Triacontyl acetate - - + - - - - - 
166  Heneicosyl trifluoroacetate - - +  - - - - 
167  Oxirane - - + - - - - - 
Legend: Present in Ghana (PA) only            Present in South Africa (PA) only                  Present in both Ghana and South Africa (PA)             
 
n = 167, n represents the total number of chemical compounds identified inclusive of repeated compounds
+ + + 
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4. Conclusions 
This comparative investigation examined similarities of chemical compounds found in standard 
COA®, solvent extracts of COA® and leaf extracts of V. amygdalina and P. americana (Ghana and 
South Africa) in four different solvents (DCM, hexane, ethanol and ethyl acetate), to establish a 
scientific rationale in the pharmacological properties of medicinal plants collected from the two 
different locations (Ghana and South Africa). It also investigated the effect of geographical location 
of each species in terms of similar and different chemical compounds in the leaf extracts of V. 
amygdalina and P. americana. A qualitative chemical examination of different ethanolic extracts of 
V. amygdalina and P. americana showed the presence of alkaloids, anthraquinones derivatives, 
saponins, flavonoids, tannins, terpenoids, and cardiac glucosides. Following the GC-MS analysis, the 
major chemical compounds common to all four solvents used for the extraction are octadecanoic 
acid, phytol acetate, pentadecanoic acid, and heneicosane.   
In terms of geographical location, results indicated substantial differences and moderate similarities 
in chemical compounds in all four solvents of extraction for V. amygdalina species from the two 
geographical areas. P. americana showed mild differences in chemical compounds from the two 
regions.   
It can be concluded that COA® herbal medicine contains leaf extracts of V. amygdalina and P. 
americana and that geographical and environmental factors have a profound effect on the 
phytochemical compounds present in leaf extracts of the two plant species from Ghana and South 
Africa.  
Further studies are warranted to establish whether the presence of the identified bioactive components 
in the four solvent leaf extracts are responsible for the pharmacological and biological properties of 
the COA® herbal medicine.  
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CHAPTER 4 - SYNTHESIS CHAPTER  
Synthesis and discussion - the significance of major findings  
Ethnomedicinal use and pharmacological properties for Persea americana and Vernonia 
amygdalina  
Plant extracts have been used in recent years as biological controls in the treatment of diseases with 
most ideas obtained from ethnomedicinal uses of leaf extracts of V. amygdalina and P. americana. 
These plants are used by local communities in almost all African countries for the management of 
various diseases.1,2 Ethnomedicine is an alternative to modern allopathic medicines.3    
Aqueous leaf of V. amygdalina is gargled in the mouth for the treatment of toothache in Cameroon,4 
In an in vivo study of aqueous leaf extract of P. americana against CCl4-induced toxicity in rat, the 
extract showed hepatoprotective activity (Brai et al 2014) and in vitro study revealed the antidiabetic 
effect on type 2 diabetes5 with also antifungal activities.6    
Hexane leaf extracts of P. americana have antimicrobial activity 7An in vitro study in Cameroon, of 
dichloromethane extract of V. amygdalina indicated its antiplasmodial activity8 with no toxicity.   
Results of the phytochemicals screening   
Phytochemicals study of  P. americana and V. amygdalina leaf extracts indicated that both plants 
contain alkaloids, flavonoids, saponins, tannins, phlobatannins, terpenoids, anthraquinone, and 
glycosides.9 These classes of phytochemicals are in concordance with conclusions made by Asaolu 
et al. (2010), of the class of phytochemicals found in the aqueous and methanolic extracts of dried 
leaves of Persea americana and Vernonia amygdalina.10 The same author concluded that the 
presence of phytochemicals and antioxidants provides evidence of the hypotensive activities of P. 
americana and V. amygdalina leaf extracts. These plants have been used by local people for the 
treatment of diseases such as hypertension, diabetes, inflammation, and cancer. This perhaps could 
probably support the information about the traditional uses of these plants in the treatment and 
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GC-MS analysis of COA® herbal medicine extract in DCM, Hex, EtOH, and EtOAc   
Leaf extracts of P. americana and V. amygdalina have beneficial pharmacological and biological 
activities reported in the literature. Much work needs to be done on the identification and isolation 
of compounds responsible for their reported pharmacological activities.  In this study, the intention 
of using GC-MS analysis is to identify the phytochemicals present in the COA® herbal medicine 
(standard),  COA® extract and leaf extracts of P. americana and V. amygdalina (from Ghana and 
South Africa) in four solvents (DCM, Hex, EtOH, and EtOAc).    
Results of the GC-MS data showed four major compounds that are common to all four solvent of 
extraction. These major chemical compounds are octadecanoic acid, phytol acetate, pentadecanoic 
acid, and heneicosane.    
   
Phytol acetate is an acetylated derivative of phytol. Phytol has anticonvulsant12 properties and as 
such, phytol acetate is expected to have similar pharmacological effects. Al-Marzoqi et al. (2016) 
indicated the presence of phytol and phytol acetate in a GC-MS analysis of seed extracts of Cassia 
angustifolia in a study to evaluate the antimicrobial property of the seed.13 The same author indicated 
that phytol acetate has anti-inflammatory, antileishmanial and antitrypanosomal properties.    
 Another author confirmed the presence of phytol in n-hexane extract and phytol acetate in ethyl 
acetate and methanol extracts of Ficus mucoso leaf extracts.14    
Octadecanoic acid is found in leaf extracts of S. nigrum and has been reported to have antibacterial 
properties in an in vitro assay against Escherichia coli, Proteus mirabilis, Staphylococcus aureus, 
Pseudomonas aerogenosa, and Klebsiella pneumonia.15 The presence and pharmacological 
properties of octadecanoic acid are affirmed by the GC-MS analysis of an ethanolic extract of 
Evolvulus alsinoides amongst others as a chemopreventive agent, anticancer, anti-microbial activity, 
antioxidant and antidiabetic properties.16   
 Pentadecanoic acid and heneicosane were also major compounds found in the leaf extract of P. 
americana and V. amygdalina and affirmed by Jiang et al (2015), who in a GC-MS analysis found 
pentadecanoic acid, heneicosane and octadecanoic acid in leaf extracts of sugarcane and maize.17   
The presence of these secondary metabolites may contribute to the different therapeutically benefits 
of COA® herbal medicine.    
Variations in the phytochemicals due to the difference in the geographical locations  
Substantial differences were observed in the contents of the active ingredients of different extracts 
collected from the two locations (Ghana and South Africa). Banerjee and Bonde (2011) concluded 
in their study that, there were major differences in composition and contents of phenolics extracts of 
the bark of Bridelia. retusa due to the dielectric constant of the solvents and geographical locations 
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of plant and the effect of climate.18 Reports show a huge effect of geographical location on 
antioxidant activity and vitamin C contents of guava fruit.19  
Most phytochemicals were found in V. amygdalina (Ghana) i.e. 94 out of 180 compounds. In the case 
of P. Americana, results are more or less similar although that of Ghana has slightly higher 
compounds. In the case of P. americana (Ghana), there were 61 chemical compounds present, where 
as in P. americana (South Africa) 52 compounds out of 167 total. The presence of variations in the 
chemical constituents in samples collected from the two different locations signifies that the 
environmental conditions and geographical locations have an impact in the chemical constituents of 
the plants.   
General conclusions  
The overall aim of this study was to evaluate and compare the different phytochemicals present in 
COA® herbal medicine and crude extracts of V. amygdalina and P. americana collected from 
Ghana and South Africa by phytochemical screening methods and GC-MS analysis. The purpose of 
this study was to know the exact phytochemicals present in COA® herbal medicine. Integrating the 
findings for all of the active ingredients and the geographical factors of each plants extracts, it is 
concluded that V. amygdalina and P. americana collected from Ghana have more phytochemicals 
than the same species in South Africa due to the differences in environmental conditions in the two 
countries. There is a lack of phytol acetate in V. amygdalina (SA) leaf extract. This variation in 
chemical constituent suggests the diversity in biotic and abiotic factors in both countries such as 
geographical location, environmental conditions, and seasonal variation. Phytochemicals present in 
leaf extracts of V. amygdalina and P. americana gives a scientific basis to validate the different 
pharmacological and therapeutics benefits of leaf extract of V. amygdalina and P. americana. 
Based on results, it is concluded that COA® herbal medicine contains P. americana and V. 
amygdalina leaf extracts.    
Recommendations for further research  
Based on the present study, recommendations are made for these ethnobotanically useful plant 
species. These are as follows:   
• Although the phytochemical screening of both the plants from different locations has 
been done, there is still a need to validate the reason for the difference in the 
phytoconstituents.   
• Further studies on the isolation of active constituents are required.   
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• There is a need to advance research for the herbal formulation development and 
evaluation of these plants.   
• Further in-vitro and in-vivo work is needed to evaluate the pharmacological effects 
of these plants.   
• Further in-vitro and in-vivo studies using different solvents of extraction and their 
effects in biological systems are needed. 
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1 / 16 
1.75  2H-Pyran-2,6(3H)-dione 
4.33  3-Piperidinol 
2.34  Toluene 
1.20 Acetic acid, butyl ester 
5.52  3-Hexen-1-ol, (E)- 
3.88  Formic acid, hexyl ester 
8.26  Heptanoic acid 
5.55  Butanedioic acid, methyl- 
3.18  3,4-Dihydroxy-5-methyl-dihydrofuran-2-one 
2.85  3-Hexenoic acid, (E)- 
2.91  2-Hexenoic acid 
4.32  2-Hexenoic acid 
3.34  2-Hexenoic acid 
6.09  2-Hexenoic acid 
2.93  2-Propanol, 1-chloro-3-(octylsulfinyl)- 




































































































Peak Report TIC 
25.0 
min 
20.0 10.0 3.0 
947,296 
TIC 
: C:\Shimadzu GCMS\Raw Data 2018-9\UKZN - M Nlooto\M Nlooto - split.qgm 







: 2018/11/08 3:44:39 PM 
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Qualitative Analysis Report 
 
 
GC-MS ANALYSIS OF COA  
(DCM)- EXTRACT 
 
















: C:\Shimadzu GCMS\general - split.qgm 
: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 07 03.qgt 
Chromatogram DCM 
TIC 
10.0 20.0 24.0 
min 




































































































































































1.93  2-Penten-1-ol, (Z)- 
3.62  Butanoic acid 
1.52  Butanoic acid, 3-methyl- 
3.77  4-Hexen-1-ol, (Z)- 
1.63  2-Hexen-1-ol, (E)- 
1.56  Formic acid, hexyl ester 
4.96  Pentanoic acid 
2.80  3-Pentanol, 2-chloro-4-methyl-, (R*,S*)-(.+/-.) 
1.49  o-Xylene 
1.32  Ethanol, 2-butoxy- 
2.06  Butanoic acid, 4-hydroxy- 
1.75  Cyclopentane, 1,2,3,4,5-pentamethyl- 
4.25  2-Heptanol, acetate 
2.43  1-Heptene, 4-methyl- 
5.34  2H-Pyran-2,6(3H)-dione 
8.45  Hexanoic acid 
5.46  3-Hexenoic acid, (E)- 
2.03  Methoxymethylaminoacrylonitryl 
5.36  Benzyl alcohol 
7.66  2(3H)-Furanone, 5-ethyldihydro- 
10.91  2-Hexenoic acid, (E)- 
2.43  Furyl hydroxymethyl ketone 
2.30  .alpha.-Methyl-.alpha.-[4-methyl-3-pentenyl]o 
2.42  1-Cyclohexyl-2-nitropropane-1,3-diol 
4.66  Maltol 
2.95  Cyclohexene,4-butyl- 






























































































































































































































   




                                 
 
   




























































































































































1.93  2H-Pyran-3-ol, 6-ethenyltetrahydro-2,2,6-trim 
1.86  Methyl salicylate 
4.85  Cyclopentan-1-al, 4-isopropylidene-2-methyl- 
2.28  1-Methyl-3-butenyl 3-methyl-3-hydroxybutyl e 
3.40  2-Carene 
6.19  7-Octen-3-ol, 2,3,6-trimethyl- 
1.45  Pentadecane 
7.90  p-Ethoxybenzyl alcohol 
2.03  2,2'-Bioxepane 
1.36  2,2'-Bioxepane 
3.62  Furan, 2,5-diethyltetrahydro- 
2.55  1,5-Heptadien-4-ol, 3,3,6-trimethyl- 
1.74  Tetradecane 
3.51  2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4 
3.43  Z-5-Nonadecene 
8.34  Epiglobulol 
2.53  1-Naphthalenol, decahydro-1,4a-dimethyl-7-(1 
3.13  Oleyl alcohol, trifluoroacetate 
4.60  1,1,6-trimethyl-3-methylene-2-(3,6,10,13,14-p 
4.12  2-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)- 
2.54  Heneicosane 
3.62  n-Tetracosanol-1 
7.20  n-Nonadecanol-1 
4.96  Heneicosane 






































































































































































































































































































































































































































Analyzed                     : 2018/08/02 12:14:05 AM 
Sample Type                : Unknown 
Sample Name              : Hexane Extract -COA 
Sample ID                   : Akwasi 
 
Vial #                          : 78 
Injection Volume         : 1.00 
 
Method File                 : C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 






































3.0                                                                10.0                                                                                             20.0                                           25.0 
min 
Peak Report TIC 
Peak# R.Time Area Area% Height Height% A/H Name 
1 2.663 778958 1.07 161051 0.67 4.84  Formamide, N,N-dimethyl- 
2 3.625 120940 0.17 58621 0.24 2.06  Butanoic acid, 4-hydroxy- 
3 4.047 223064 0.31 114252 0.48 1.95  Benzonitrile, 3-hydroxy- 
4 4.209 185807 0.26 112389 0.47 1.65 Aniline 
5 4.268 471337 0.65 184052 0.77 2.56  3-Hexenoic acid, (E)- 
6 4.324 1205361 1.66 413057 1.72 2.92  2H-Pyran-2,6(3H)-dione 
7 4.479 1347776 1.86 321557 1.34 4.19  2-Hexenoic acid, (E)- 
8 4.623 189033 0.26 54530 0.23 3.47  Dehydromevalonic lactone 
9 5.718 194870 0.27 77748 0.32 2.51  1-Octadecyne 
10 6.106 420081 0.58 383580 1.60 1.10  Dodecane 
11 7.324 268507 0.37 268792 1.12 1.00  Tridecane, 5-methyl- 
12 7.685 1230117 1.70 971056 4.05 1.27  Tetradecane 
13 8.408 148227 0.20 66700 0.28 2.22  Tetradecane, 4-methyl- 
14 8.480 783934 1.08 642633 2.68 1.22  Butylated Hydroxytoluene 
15 8.765 1129563 1.56 851685 3.55 1.33  Tetradecane, 5-methyl- 
16 9.098 1003128 1.38 895865 3.74 1.12  Hexadecane 
17 9.646 393664 0.54 203783 0.85 1.93  Pentadecane, 8-hexyl- 
18 9.790 367323 0.51 118908 0.50 3.09  Pentadecane, 8-hexyl- 
19 9.956 293210 0.40 149113 0.62 1.97  Heptadecane, 3-methyl- 
20 10.062 1656359 2.28 1066922 4.45 1.55  Tetradecane, 5-methyl- 
21 10.157 116886 0.16 93947 0.39 1.24  2-Methylhexadec-1-ene 
22 10.366 747710 1.03 488455 2.04 1.53  Heptadecane 
23 10.448 240092 0.33 127358 0.53 1.89  2-methyltetracosane 
24 10.590 610159 0.84 332145 1.39 1.84  Phytol, acetate 
25 10.818 753696 1.04 264795 1.11 2.85  Eicosane 
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Peak# R.Time Area Area% Height Height% A/H Name 
27 11.287 4979187 6.86 1886799 7.87 2.64  l-(+)-Ascorbic acid 2,6-dihexadecanoate 
28 11.515 805612 1.11 306001 1.28 2.63  Eicosane 
29 11.637 445991 0.61 110282 0.46 4.04  Methyl 2-bromo-5-methoxybenzoate 
30 11.884 582737 0.80 320143 1.34 1.82  Pentadecane, 8-hexyl- 
31 11.988 357830 0.49 152438 0.64 2.35  Trifluoroacetoxy hexadecane 
32 12.102 491221 0.68 195788 0.82 2.51  Pyrene 
33 12.281 2075165 2.86 166555 0.70 12.46  9-Octadecenal, (Z)- 
34 12.366 1219202 1.68 432441 1.80 2.82  Octadecanoic acid 
35 12.564 604559 0.83 276795 1.16 2.18  Eicosane 
36 12.599 602835 0.83 214205 0.89 2.81  1-Dodecanol, 2-octyl- 
37 12.782 116332 0.16 38994 0.16 2.98  Hexadecanoic acid, 2-hydroxyethyl ester 
38 12.874 1179933 1.63 381355 1.59 3.09  Pentadecane, 8-hexyl- 
39 12.957 108682 0.15 35656 0.15 3.05  2-methyltetracosane 
40 13.056 301585 0.42 162837 0.68 1.85  Tetracosane, 11-decyl- 
41 13.292 1052914 1.45 667706 2.79 1.58  Docosane, 2,4-dimethyl- 
42 13.532 616670 0.85 152108 0.63 4.05  Tetratetracontane 
43 13.632 1835402 2.53 1453195 6.06 1.26  Phenol, 2,2'-methylenebis[6-(1,1-dimethylethy 
44 13.787 1128730 1.56 336187 1.40 3.36  Hexatriacontane 
45 13.983 479001 0.66 145955 0.61 3.28  2-methylhexacosane 
46 14.119 169364 0.23 96418 0.40 1.76  2-methyloctacosane 
47 14.199 656372 0.90 442347 1.85 1.48  Docosane, 7-hexyl- 
48 14.412 995660 1.37 173246 0.72 5.75  Hexatriacontane 
49 14.636 1173440 1.62 346092 1.44 3.39  Tetratetracontane 
50 14.759 399803 0.55 119226 0.50 3.35  2-methyloctacosane 
51 14.834 379649 0.52 159570 0.67 2.38  Tetratetracontane 
52 14.965 459810 0.63 117974 0.49 3.90  3,3,13,13-Tetraethylpentadecane 
53 15.042 491996 0.68 259778 1.08 1.89  Tetracosane, 11-decyl- 
54 15.219 1388505 1.91 212483 0.89 6.53  Tetratetracontane 
55 15.430 2164601 2.98 419866 1.75 5.16  Tetratetracontane 
56 15.557 532749 0.73 144058 0.60 3.70  2-methylhexacosane 
57 15.632 455687 0.63 218721 0.91 2.08  2-methylhexacosane 
58 15.757 1119538 1.54 173867 0.73 6.44  Hexadecane, 1-iodo- 
59 15.832 507747 0.70 232439 0.97 2.18  Docosane, 2,4-dimethyl- 
60 15.988 2178389 3.00 300630 1.25 7.25  Tetratetracontane 
61 16.210 3616869 4.99 429166 1.79 8.43  Hexatriacontane 
62 16.373 708467 0.98 195273 0.81 3.63  Sulfurous acid, octadecyl 2-propyl ester 
63 16.454 1008344 1.39 199745 0.83 5.05  Hexatriacontane 
64 16.540 555638 0.77 210273 0.88 2.64  Cholesta-4,6-dien-3-ol, (3.beta.)- 
65 16.692 2148935 2.96 236841 0.99 9.07  Octadecane, 5-methyl- 
66 16.864 2324649 3.20 295415 1.23 7.87  Hexatriacontane 
67 17.132 3524432 4.86 399319 1.67 8.83  Hexatriacontane 
68 17.353 1086268 1.50 124464 0.52 8.73  Decane, 1-bromo-2-methyl- 
69 17.481 736123 1.01 119307 0.50 6.17  Stigmasterol 
70 17.657 389680 0.54 74444 0.31 5.23  6,6-Diethylhoctadecane 
71 17.773 339423 0.47 60727 0.25 5.59  Sulfurous acid, octadecyl 2-propyl ester 
72 17.859 837788 1.15 278411 1.16 3.01  .gamma.-Sitosterol 
73 17.975 676353 0.93 201522 0.84 3.36  2-methylhexacosane 
74 18.104 465918 0.64 97390 0.41 4.78  Silane, dimethyl(docosyloxy)butoxy- 
75 18.333 1234800 1.70 193522 0.81 6.38  Triacontane, 1-bromo- 
76 18.473 129385 0.18 54852 0.23 2.36  Testosterone Valerate 
77 19.473 432381 0.60 120761 0.50 3.58  Tetratetracontane 
78 19.717 3204314 4.42 995181 4.15 3.22 Acetic acid, (2,4-dichlorophenoxy)-, isooctyl e 
79 19.950 540229 0.74 96557 0.40 5.59  Hexatriacontane 
80 21.544 232439 0.32 58842 0.25 3.95  Hexatriacontane 
81 22.207 322847 0.45 65441 0.27 4.93  Nonahexacontanoic acid 
82 23.233 705182 0.97 75586 0.32 9.33  Hexadecanoic acid, octadecyl ester 
83 24.464 179221 0.25 39018 0.16 4.59  Nonahexacontanoic acid 
  72541212 100.00 23961754 100.00  
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GC-MS ANALYSIS OF COA® 
(ETHANOL) 
  
Qualitative Analysis Report 





Peak# R.Time Area Area% Height Height% A/H Name 
1 2.530 285984 2.22 371563 3.76 0.77  Triethylamine 
2 2.906 7089544 55.04 7015466 71.01 1.01  Formamide, N,N-dimethyl- 
3 3.099 354614 2.75 161407 1.63 2.20  Benzene, chloro- 
4 3.752 159969 1.24 128487 1.30 1.25  Butanoic acid, 4-hydroxy- 
5 4.088 52912 0.41 48461 0.49 1.09  Benzene, isocyanato- 
6 4.284 100589 0.78 56113 0.57 1.79 Aniline 
7 10.590 150477 1.17 138940 1.41 1.08  Phytol, acetate 
8 10.728 58125 0.45 29354 0.30 1.98  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
9 10.845 51431 0.40 47734 0.48 1.08  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
10 11.297 616739 4.79 280537 2.84 2.20  Pentadecanoic acid 
11 12.108 230632 1.79 135127 1.37 1.71  Pyrene 
12 12.272 309975 2.41 97108 0.98 3.19  7-Tetradecenal, (Z)- 
13 12.375 194855 1.51 62566 0.63 3.11  Octadecanoic acid 
14 12.500 374603 2.91 235420 2.38 1.59  Hexadecanamide 
15 13.400 2302424 17.88 824212 8.34 2.79  9-Octadecenamide, (Z)- 
16 13.506 322573 2.50 107679 1.09 3.00  Octadecanamide 
17 14.150 64201 0.50 50028 0.51 1.28  Diisooctyl phthalate 
18 16.543 52066 0.40 32696 0.33 1.59  Cholesta-4,6-dien-3-ol, (3.beta.)- 
19 16.642 54894 0.43 37590 0.38 1.46  Stigmast-5-en-3-ol, oleate 
20 19.882 53484 0.42 18548 0.19 2.88  1,4-Methanoazulen-9-ol, decahydro-1,5,5,8a-t 




























































































Analyzed                     : 2018/08/02 12:50:08 AM 
Sample Type                : Unknown 
Sample Name              : EtOH COA Extract 
Sample ID                   : Akwasi 
 
Vial #                          : 79 
Injection Volume         : 1.00 
 
Method File                 : C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 






































3.0                                                                10.0                                                                                             20.0                                           25.0 
min 
Peak Report TIC
Qualitative Analysis Report 
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GC-MS ANALYSIS OF COA® 
(ETHYL ACETATE) 
  
Qualitative Analysis Report 





Peak# R.Time Area Area% Height Height% A/H Name 
1 2.555 3431691 0.80 1649895 0.92 2.08  Toluene 
2 2.588 5905792 1.38 1683071 0.94 3.51  Spiro[2,4]hepta-4,6-diene 
3 2.678 8296405 1.93 8862016 4.93 0.94  Toluene 
4 2.850 531202 0.12 321887 0.18 1.65  1,3-Octanediol 
5 3.080 996793 0.23 1180274 0.66 0.84  Furfural 
6 3.141 51891650 12.08 15230582 8.47 3.41  Benzene, chloro- 
7 3.226 97578624 22.72 46143666 25.65 2.11  Benzene, chloro- 
8 3.313 673716 0.16 280520 0.16 2.40  Hexyl chloroformate 
9 4.083 708808 0.17 751885 0.42 0.94  2-Furancarboxaldehyde, 5-methyl- 
10 4.486 2064553 0.48 402532 0.22 5.13  2-Hexenoic acid, (E)- 
11 8.808 983653 0.23 334391 0.19 2.94  .alpha.-Calacorene 
12 9.197 1073231 0.25 945089 0.53 1.14  4,6-Heptadien-2-one, 3,6-dimethyl-3-(1-methy 
13 9.403 467305 0.11 371504 0.21 1.26  Di-epi-.alpha.-cedrene-(I) 
14 9.513 1127272 0.26 245917 0.14 4.58  1-Naphthalenol, 1,2,3,4,4a,7,8,8a-octahydro-1 
15 9.609 717031 0.17 621897 0.35 1.15  2-Naphthalenemethanol, decahydro-.alpha.,.al 
16 9.693 2230671 0.52 1295239 0.72 1.72  Naphthalene, 1,6-dimethyl-4-(1-methylethyl)- 
17 9.726 3523123 0.82 2063957 1.15 1.71  Benzene, 1,2,4,5-tetraethyl- 
18 9.892 1926500 0.45 890231 0.49 2.16  9-Undecenal, 2,10-dimethyl- 
19 10.053 725650 0.17 362707 0.20 2.00  Neoclovene oxide 
20 10.098 3479310 0.81 2869991 1.60 1.21  1-Cyclohexanone, 2-methyl-2-(3-methyl-2-oxo 
21 10.239 1210327 0.28 383065 0.21 3.16  4-(2-Acetyl-5,5-dimethylcyclopent-2-enyliden 
22 10.323 631094 0.15 442009 0.25 1.43  Pentafluoropropionic acid, tridecyl ester 
23 10.390 2053703 0.48 1547257 0.86 1.33  2-Naphthalenemethanol, 2,3,4,4a,5,6,7,8-octa 
24 10.491 2478934 0.58 1033291 0.57 2.40  7-Oxocholesteryl isocaproate 
25 10.579 3409167 0.79 1858172 1.03 1.83  (1S,2E,4S,5R,7E,11E)-Cembra-2,7,11-trien-4, 











































































































































































































Analyzed                     : 2018/08/02 1:26:30 AM 
Sample Type                : Unknown 
Sample Name              : EtOAc- COA Extract 
Sample ID                   : Akwasi 
 
Vial #                          : 80 
Injection Volume         : 1.00 
 
Method File                 : C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 












































Qualitative Analysis Report 






Peak# R.Time Area Area% Height Height% A/H Name 
27 10.713 879058 0.20 496928 0.28 1.77  3,3,5,5-Tetramethyl-4,5-dihydro-3H-benzo[c]a 
28 10.750 992751 0.23 848798 0.47 1.17  Phthalic acid, hexyl 4-trifluoromethoxybenzyl 
29 10.924 1053068 0.25 576891 0.32 1.83  4,6,10,10-Tetramethyl-5-oxatricyclo[4.4.0.0(1 
30 11.043 1189389 0.28 428359 0.24 2.78  3-Heptyn-2-one, 5-cyclopentyl-6-hydroxy-6-m 
31 11.092 1720716 0.40 1054833 0.59 1.63  Pentadecanoic acid, 14-methyl-, methyl ester 
32 11.307 11269016 2.62 5699367 3.17 1.98  Pentadecanoic acid 
33 11.429 1714721 0.40 541332 0.30 3.17  Metolachlor 
34 11.536 1721046 0.40 488170 0.27 3.53  3-Buten-2-one, 4-(2-hydroxy-2,6,6-trimethylc 
35 11.993 532876 0.12 407903 0.23 1.31  n-Nonadecanol-1 
36 12.034 1496316 0.35 1284267 0.71 1.17  Tricyclo[3.3.1.1(3,7)]decane, 1-(phenylmethyl 
37 12.171 134992357 31.43 32159456 17.88 4.20  Benzene, 1,1'-(1,3-butadiyne-1,4-diyl)bis- 
38 12.267 19968705 4.65 6511323 3.62 3.07  cis-9-Hexadecenal 
39 12.369 2527124 0.59 1996069 1.11 1.27  Octadecanoic acid 
40 12.403 4204492 0.98 3121640 1.74 1.35  1,4-Ethenoanthracene, 1,4-dihydro- 
41 12.483 2786109 0.65 2594846 1.44 1.07  Hexadecanamide 
42 12.561 1277369 0.30 811146 0.45 1.57  Heneicosane 
43 13.303 1898633 0.44 726686 0.40 2.61  3-Furan-2-yl-acrylic acid 4-[(2-chloro-benzoyl 
44 13.389 19513229 4.54 13280547 7.38 1.47  9-Octadecenamide, (Z)- 
45 13.492 1891488 0.44 1129293 0.63 1.67  Octadecanamide 
46 13.631 640000 0.15 560934 0.31 1.14  Phenol, 2,2'-methylenebis[6-(1,1-dimethylethy 
47 14.147 3930903 0.92 3667898 2.04 1.07  Diisooctyl phthalate 
48 15.204 556045 0.13 438181 0.24 1.27  13-Docosenamide, (Z)- 
49 17.483 774186 0.18 381948 0.21 2.03  Stigmasterol 
50 17.852 2290068 0.53 984875 0.55 2.33  .gamma.-Sitosterol 
  429493080 100.00 179896579 100.00  
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1.21  3,4-Dimethyl-2-pentanone 
1.13  Heptadecanal 
1.30  Tetradecanoic acid 
1.74 Acetic acid, 2-(2,2,6-trimethyl-7-oxa-bicyclo[4 
2.18  2,6,8-Trimethylbicyclo[4.2.0]oct-2-ene-1,8-di 
1.58  Phytol, acetate 
1.68  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.59  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.40  Pentadecanoic acid 
1.24  9-Octadecen-1-ol, (Z)- 
1.05  1-Heneicosanol 
1.40  Phytol 
3.50  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
2.44  Octadecanoic acid 
2.61  Cyclopropanemethanol, 2-methyl-2-(4-methyl- 
1.55  Phytol, acetate 
1.84  E-10,13,13-Trimethyl-11-tetradecen-1-ol aceta 
1.44  1-Heneicosanol 
3.16  Methyl 12-oxo-9-dodecenoate 
3.12  Eicosanoic acid 
2.38  1-Octadecanesulphonyl chloride 
1.70  Hexadecanoic acid, 2-hydroxy-1-(hydroxymet 
1.59  Diisooctyl phthalate 
2.74  Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-c 
3.28  12-Methyl-E,E-2,13-octadecadien-1-ol 
1.80  13-Docosenamide, (Z)- 




































































































































































































































































































   
  
  
    
  
         








     
























































































































































































































1.42  Squalene 
1.50  Tetratetracontane 
1.52  Oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentam 
3.61  Hexadeca-2,6,10,14-tetraen-1-ol, 3,7,11,16-tet 
5.15  17-(1,5-Dimethyl-hex-2-enyl)-10,13-dimethyl- 
2.27  Tetratetracontane 
2.84  2-(8-Chloro-3,7-dimethyl-octa-2,6-dienyloxy)t 
2.24  Hexadecanal 
2.70  .gamma.-Tocopherol 
2.05  Tetratetracontane 
3.01  9-Octadecanone 
2.63  Vitamin E 
3.45  9-Octadecenoic acid, 1,2,3-propanetriyl ester, 
4.80  Tetratetracontane 
4.23  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
4.09  Hexadecanal 
4.75  Ergost-5-en-3-ol, (3.beta.)- 
2.43  Stigmasterol 
2.23  Docosyl trifluoroacetate 
2.78  Chondrillasterol 
3.26  Chondrillasterol 
3.32  Methanesulfonic acid, 2-(3-hydroxy-4,4,10,13 
3.55  Stigmasterol 
5.84  4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6, 
3.61  2,2,4-Trimethyl-3-(3,8,12,16-tetramethyl-hept 
4.76  Hexadecanal 
2.88  .alpha.-Amyrin 
2.87  Tetracosyl pentafluoropropionate 
2.57  2-Nonadecanone 
3.11  Phytol, acetate 
3.92  E,E,Z-1,3,12-Nonadecatriene-5,14-diol 
5.77  Phytol, acetate 
3.15  Oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentam 
5.89  Phytol, acetate 
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1.31  Undecane, 3,8-dimethyl- 
1.15  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.09  Phytol, acetate 
1.28  2-Pentadecanone, 6,10,14-trimethyl- 
1.23  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.09  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.05  1-Hexacosene 
1.74  Pentadecanoic acid 
1.66  9-Octadecen-1-ol, (Z)- 
1.69  1-Octadecanol 
1.20  2-Ethylnon-1-en-3-ol 
1.82  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.18  13-Octadecenal, (Z)- 
2.87  Octadecanoic acid 
1.92  Pentadecanal- 
1.73  11,13-Dimethyl-12-tetradecen-1-ol acetate 
2.40  2-methyltetracosane 
1.08  Tetratetracontane 
1.61  13-Docosenamide, (Z)- 
1.21  Tetradecanamide 
1.06  Hexadecanal 
1.50  2-methyloctacosane 
1.24  Tetratetracontane 
1.48  Hexadecanal 
1.53  .gamma.-Tocopherol 
1.35  Tetratetracontane 


































































































































































































    
  
   
  
 
   
































































































1.92  n-Tetracosanol-1 
1.90  2-Nonadecanone 
1.74  Stigmast-5-en-3-ol, oleate 
1.76  1,19-Eicosadiene 
2.04  Tetracosyl acetate 
1.72  Oxirane, heptadecyl- 
1.69  2-methylhexacosane 
2.29  Tetracosyl trifluoroacetate 
2.62  2-Nonadecanone 
3.00  .gamma.-Sitosterol 
2.66  Triacontyl acetate 
2.11  Hexadecanal 
3.11  Tetracosyl trifluoroacetate 
2.55  2-Nonadecanone 
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1.10  Heptadecanal 
1.13  Tetradecanoic acid 
1.12  Phytol, acetate 
1.15  2-Pentadecanone, 6,10,14-trimethyl- 
1.73  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.62  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.73  Pentadecanoic acid 
1.40  9-Octadecen-1-ol, (Z)- 
1.07  1-Heneicosanol 
1.63  Phytol 
2.29  9,12-Octadecadienoic acid (Z,Z)- 
1.95  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
1.73  Octadecanoic acid 
2.78  Cyclopropanemethanol, 2-methyl-2-(4-methyl- 
2.02  1-Hexadecanol, 2-methyl- 
1.39  E-10,13,13-Trimethyl-11-tetradecen-1-ol aceta 
1.04  n-Nonadecanol-1 
1.52  Eicosanoic acid 
1.71  2,6,10,14,18-Pentamethyl-2,6,10,14,18-eicosa 
1.93  2-methyloctacosane 
1.47  Hexadecanoic acid, 2-hydroxy-1-(hydroxymet 
1.12  Diisooctyl phthalate 
1.14  2-methyloctacosane 
1.77  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
1.26  9-Octadecenamide, (Z)- 
1.36  Heneicosane 








































































































































































































































































































    
  
             





   
  
    
  
   
























































































































































































































1.19  Squalene 
1.29  Hexadecanal 
1.92  Tetratetracontane 
1.29  1,6,10,14,18,22-Tetracosahexaen-3-ol, 2,6,10, 
1.84  Oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentam 
1.34  Tetratetracontane 
1.47  Hexadecanal 
1.33  .gamma.-Tocopherol 
3.54  Tetratetracontane 
1.75  2-Nonadecanone 
1.80  Stigmast-5-en-3-ol, oleate 
2.13  Vitamin E 
1.59  Tetratetracontane 
2.32  11,13-Dimethyl-12-tetradecen-1-ol acetate 
2.49  Ergosterol 
1.88  Cholest-22-ene-21-ol, 3,5-dehydro-6-methoxy 
2.39  Triacontyl trifluoroacetate 
2.34  Chondrillasterol 
1.93  .gamma.-Ergostenol 
1.83  Phytol, acetate 
2.39  Chondrillasterol 
3.35  9,19-Cyclolanost-23-ene-3,25-diol,  3-acetate, 
2.25  4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6, 
2.72  Lup-20(29)-en-3-ol, acetate, (3.beta.)- 
3.37  dl-.alpha.-Tocopherol 
2.64  .alpha.-Amyrin 
2.61  2-Nonadecanone 
2.80  Lanosterol 
3.14  Phytol, acetate 
2.26  Hexadecanoic acid, octadecyl ester 
4.02  E,E,Z-1,3,12-Nonadecatriene-5,14-diol 
5.31  Phytol, acetate 
3.37  Hexadecanoic acid, octadecyl ester 
5.99  Phytol, acetate 
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1.30  Benzene, chloro- 
1.56  Phytol, acetate 
2.39  9-(3,3-Dimethyloxiran-2-yl)-2,7-dimethylnona 
2.89  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.73  Pentadecanoic acid 
1.91  Pyrene 
2.86  Phytol 
5.09  cis-9-Hexadecenal 
4.25  Octadecanoic acid 
3.31  Sulfurous acid, 2-propyl tridecyl ester 
2.93  13-Docosenamide, (Z)- 
11.55  Isosteviol 
6.44  1,2-Epoxynonane 
1.74  Bis(tridecyl) phthalate 
1.34  Squalene 
1.66  Hexatriacontane 
6.52  Cyclopropa[5,6]stigmast-22-en-3-ol,  3',6-dihy 
3.62  17-Acetyl-14-hydroxy-16-methoxy-10,13-dim 
4.20  Trimethylsilyl 3-methyl-4-[(trimethylsilyl)oxy] 
1.80  2-methyltetracosane 
5.71  .gamma.-Tocopherol 
1.66  Hexatriacontane 
1.98  Cholesta-4,6-dien-3-ol, (3.beta.)- 
3.57  Stigmast-5-en-3-ol, oleate 
2.78  Octadecane, 1,1'-[1,3-propanediylbis(oxy)]bis 
5.92  d-Glucitol, 2,5-anhydro-1-O-octyl- 






































































































































































































































































5.75  .gamma.-Sitosterol 
3.84  2-t-Butyl-5-(dimethoxy-phosphoryl)-3-methyl- 
3.11  Oxirane, hexadecyl- 
4.79  2-t-Butyl-5-(dimethoxy-phosphoryl)-3-methyl- 
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1.47  2,3-Hexanedione 
0.96  2,3-Butanediol, [R-(R*,R*)]- 
1.74  2,3-Butanediol 
0.83  Methoxyacetic acid, 2-pentyl ester 
0.83  3-Hexanol, 2-methyl- 
1.35  Butyrolactone 
0.85  Pentane, 1,1-diethoxy- 
1.36  Benzeneacetic acid 
3.03  Valeric acid, 2,3-epoxy-3,4-dimethyl-, ethyl es 
1.33  (E)-1-(2,3,6-trimethylphenyl)buta-1,3-diene (T 
7.45  Erythritol 
0.91  Phosphoric acid, diethyl octyl ester 
1.44  Dodecanoic acid 
4.13  D-Allose 
1.79  .beta.-D-Glucopyranose, 1,6-anhydro- 
0.93  Hexadecane 
2.32  .beta.-d-Ribopyranoside, methyl, 3-acetate 
4.87  Megastigmatrienone 
5.06  d-Glycero-d-tallo-heptose 
1.05  Tetradecanoic acid 
1.42  5-Isopropyl-6-methyl-hepta-3,5-dien-2-ol 
1.29  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.29  Phytol, acetate 
1.55  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.47  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.27  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 




























































































































































































































































































































































































                             
  



























































































































































































































































































































































































2.27  1-Hexadecen-3-ol, 3,5,11,15-tetramethyl- 
2.93  Pentadecanoic acid 
1.50  Docosanoic acid, ethyl ester 
2.72  Octanoic acid, octyl ester 
1.48  9-Octadecen-1-ol, (Z)- 
1.04  3-Eicosene, (E)- 
1.35  Phytol 
2.59  9,12-Octadecadienoic acid (Z,Z)- 
1.76  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
1.49  Octadecanoic acid 
2.28  trans-2-[2'-(2''-Methyl-1''-propenyl)cyclopropy 
1.74  Pentalene, octahydro-2-[(2-octyl)decyl]- 
2.19  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
1.67  1-Heneicosanol 
1.71  2-Dodecylcyclobutanone 
1.58  9-Octadecenal, (Z)- 
2.20  Eicosane, 2-cyclohexyl- 
1.77  Eicosanoic acid 
1.36  Hexadecanal, 2-methyl- 
1.26  Hexadecanoic acid, 2-hydroxy-1-(hydroxymet 
2.25  Bicyclo[6.1.0]nonane, 9-(1-methylethylidene)- 
1.42  Hexadecanoic acid, 2-hydroxy-1-(hydroxymet 
1.84  Methanol, [6,8,9-trimethyl-4-(1-propenyl)-3-o 
1.07  Octadecanoic acid 
2.95  Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-c 
1.95  9,12-Octadecadienoic acid (Z,Z)-, 2,3-dihydro 
1.86  9,12,15-Octadecatrienoic acid, (Z,Z,Z)- 
1.68  9,12-Octadecadienoic acid (Z,Z)-, 2-hydroxy- 
2.34  1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetr 
2.42  Octadecanoic acid, 2,3-dihydroxypropyl ester 
1.27  9-Octadecenamide, (Z)- 
1.15  Squalene 
1.44  (E,E,E)-3,7,11,15-Tetramethylhexadeca-1,3,6, 
2.02  Hexadecane, 1-bromo- 
1.95  Cyclohexane, 1,2,3,5-tetraisopropyl- 
2.61  3H-Naphtho[2,3-b]furan-2-one, 4-hydroxy-4a, 
1.24  17-(1,5-Dimethyl-hex-2-enyl)-10,13-dimethyl- 
1.30  (E,E,E)-3,7,11,15-Tetramethylhexadeca-1,3,6, 
1.89  2-(8-Chloro-3,7-dimethyl-octa-2,6-dienyloxy)t 
1.64  .gamma.-Tocopherol 
2.19  n-Tetracosanol-1 
1.56  Vitamin E 
1.98  Lycoxanthin 
2.52  1,6,10,14,18,22-Tetracosahexaen-3-ol, 2,6,10, 
1.76  15,17,19,21-Hexatriacontatetrayne 
1.87  Ergost-5-en-3-ol, (3.beta.)- 
2.00  Stigmasterol 
2.14  Chondrillasterol 
1.89  Stigmasta-4,7,22-trien-3.alpha.-ol 
2.65  Chondrillasterol 
1.96  Cholest-7-en-3-ol, 2,2-dimethyl-, (3.beta.,5.alp 
2.52  5,8,11-Eicosatriynoic acid, methyl ester 
2.14  4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6, 
3.77  10,12,14-Nonacosatriynoic acid 
2.66  .alpha.-Amyrin 
2.55  Phytol, acetate 
2.85  cis-13,16-Docasadienoic acid, tert-butyldimeth 
4.60  E,E,Z-1,3,12-Nonadecatriene-5,14-diol 
4.91  Phytol, acetate 
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1.12  Phytol, acetate 
1.24  2-Pentadecanone, 6,10,14-trimethyl- 
1.73  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.20  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.08  1-Hexacosene 
1.31  Pentadecanoic acid 
1.68  Pentanoic acid, 4-hexadecyl ester 
1.19  .gamma.-Dodecalactone 
2.86  Phytol 
0.94  Cyclopentanone, 2-(5-oxohexyl)- 
1.24  Hexadecanamide 
1.64  9-Octadecenamide, (Z)- 
1.79  Octadecanamide 
1.73  13-Docosenamide, (Z)- 
3.04  Ergosta-7,22-dien-3-ol, (3.beta.,5.alpha.,22E)- 
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1.19  o-Xylene 
1.12  Phytol, acetate 
1.45  2-Pentadecanone, 6,10,14-trimethyl- 
1.54  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.67  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.24  Pentadecanoic acid 
1.04  9-Octadecen-1-ol, (Z)- 
1.06  1-Heneicosanol 
1.18  Phytol 
2.83  cis,cis,cis-7,10,13-Hexadecatrienal 
1.48  Octadecanoic acid 
0.94  Phytol, acetate 
1.08  n-Nonadecanol-1 
1.71  Eicosanoic acid 
2.02  8-Methylenecyclooctene-3,4-diol 
1.95  Hexadecanoic acid, 2-hydroxy-1-(hydroxymet 
2.56  Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-c 
1.52  2-methylhexacosane 
1.67  (.+/-.)-Lavandulol, chlorodifluoroacetate 
1.19  9-Octadecenamide, (Z)- 
1.66  2-methyltetracosane 
1.25  Squalene 
1.18  Tetratetracontane 
1.16  Oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentam 
1.73  Tetratetracontane 
2.44  2-(8-Chloro-3,7-dimethyl-octa-2,6-dienyloxy)t 








































































































































































































































    
         
    
           









    






























































































































1.96  Oxirane, heptadecyl- 
1.88  .gamma.-Tocopherol 
1.46  Tetratetracontane 
1.46  n-Tetracosanol-1 
2.18  9-Octadecanone 
1.61  Vitamin E 
2.35  Ergosterol 
1.79  Stigmasterol 
1.86  Eicosyl heptafluorobutyrate 
1.87  Chondrillasterol 
2.53  Chondrillasterol 
1.88  .alpha.-Amyrin 
4.53  1-Phenanthrenemethanol, 1,2,3,4,4a,9,10,10a- 
2.30  dl-.alpha.-Tocopherol 
2.31  .alpha.-Amyrin 
2.62  Phytol, acetate 
3.06  1,1':3',1''-Tercyclopentane, 2'-dodecyl- 
4.84  Phytol, acetate 
4.65  Phytol, acetate 
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0.79  Toluene 
1.30  Ethylbenzene 
1.47  Benzene, 1,3-dimethyl- 
1.28  Benzene, 1,3-dimethyl- 
1.24  Benzene, 1-ethyl-3-methyl- 
1.38  Benzene, 1-ethyl-3-methyl- 
1.94  3,4-Dimethyl-2-pentanone 
1.95  1-Heptanol, 2-propyl- 
1.28  2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4 
1.55  Tetradecanoic acid 
1.52 Acetic acid, 2-(2,2,6-trimethyl-7-oxa-bicyclo[4 
1.08  Phytol, acetate 
1.65  2-Pentadecanone, 6,10,14-trimethyl- 
1.47  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.69  3-Eicosene, (E)- 
1.09  1-Hexacosene 
1.73  Pentadecanoic acid 
1.34  9-Octadecen-1-ol, (Z)- 
1.30  1-Heneicosanol 
1.03  .gamma.-Dodecalactone 
1.09  Phytol 
1.96  9,12-Octadecadienoic acid (Z,Z)- 
1.93  cis,cis,cis-7,10,13-Hexadecatrienal 
2.63  Octadecanoic acid 
3.37  2-Dodecen-1-yl(-)succinic anhydride 
1.70  Tetracosane, 1-bromo- 















































































































































































































































































































































































       
           
 
  
    
    
 
  
   














































































































































































































































































































































































1.31  3,7,11-Trimethyldodecylacetate 
1.19  Phytol, acetate 
1.87  4,8,12,16-Tetramethylheptadecan-4-olide 
1.36  Eicosanoic acid 
1.57  9-Octadecenamide, (Z)- 
1.49  3,4-Xylyl 3,5-di-tert-butylbenzoate 
2.24  Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-c 
3.22  Glycerol 1-palmitate 
1.52  Diisooctyl phthalate 
3.47  12,15-Octadecadiynoic acid, methyl ester 
1.67  Cyclohexane, 1,2-diethenyl-4-(1-methylethylid 
1.49  1,1,3,3-Tetramethyl-1,3-disilacyclopentane 
2.08  Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-c 
2.03  6,10-Dodecadien-1-yn-3-ol, 3,7,11-trimethyl- 
3.09  2,6-Octadiene, 4,5-dimethyl- 
1.55  Cholesta-8,24-dien-3-ol, 4-methyl-, (3.beta.,4. 
1.31  4-(2,4,4-Trimethyl-cyclohexa-1,5-dienyl)-but- 
1.67  13-Docosenamide, (Z)- 
1.42  Isolongifolene, 9,10-dehydro- 
2.04  (3,7-Dimethyl-octa-2,6-dienyl)-benzene 
2.28  Cholesta-8,24-dien-3-ol, 4-methyl-, (3.beta.,4. 
2.44  erythro-7,8-Bromochlorodisparlure 
2.15  Cyclohexane, 1,2,3,5-tetraisopropyl- 
1.42  2-methyloctacosane 
1.40  2,6,10,14-Hexadecatetraen-1-ol, 3,7,11,15-tetr 
1.67  Squalene 
3.48  .beta.-D-Mannofuranoside, farnesyl- 
1.92  Card-20(22)-enolide, 3,14-dihydroxy-, (3.beta 
2.35  2-methyloctacosane 
3.73  2-(8-Chloro-3,7-dimethyl-octa-2,6-dienyloxy)t 
2.19 Androst-5,7-dien-3-ol-17-one, acetate 
1.25  Tetratetracontane 
1.78  n-Tetracosanol-1 
1.84  Cholesta-4,6-dien-3-ol, (3.beta.)- 
1.48  22,23-Dibromostigmasterol acetate 
1.50  Vitamin E 
1.73  2-methylhexacosane 
2.19  Hexacosyl acetate 
2.57  Ethyl iso-allocholate 
1.79  Stigmasterol 
2.43  1-Heptacosanol 
2.18  Chondrillasterol 
2.52  Ergosta-8(14),15,22-trien-3-ol, (3.beta.,5.alph 
2.28  Chondrillasterol 
2.08  7,22-Ergostadienone 
2.20  4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6, 
2.31  4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6, 
2.58  10,12,14-Nonacosatriynoic acid 
2.89  dl-.alpha.-Tocopherol 
2.76  .alpha.-Amyrin 
2.54  2-Azapentane-1,5-dione, 4-methyl-1,5-diphen 
2.28  Tricyclo[20.8.0.0(7,16)]triacontane,  1(22),7(1 
4.11  Docosyl trifluoroacetate 
3.14  2-Nonadecanone 
2.90  Lanosterol 
2.62  Phytol, acetate 
3.85  E,E,Z-1,3,12-Nonadecatriene-5,14-diol 
5.90  Tricyclo[20.8.0.0(7,16)]triacontane,  1(22),7(1 
4.91  Phytol, acetate 
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0.88  Bicyclo[3.1.0]hexane, 4-methylene-1-(1-meth 
1.01  .beta.-Pinene 
1.04  .alpha.-Cubebene 
0.97  .beta.-copaene 
1.01  Caryophyllene 
0.98  Humulene 
1.07  1,6-Cyclodecadiene, 1-methyl-5-methylene-8- 
1.33  Cyclohexane, 1-ethenyl-1-methyl-2-(1-methyle 
1.09  Heptadecanal 
1.33  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.11  Phytol, acetate 
1.52  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.42  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.64  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.43  Pentadecanoic acid 
1.20  9-Octadecen-1-ol, (Z)- 
0.94  9,17-Octadecadienal, (Z)- 
1.10  n-Nonadecanol-1 
1.07  Phytol 
1.57  11,14-Eicosadienoic acid, methyl ester 
1.93  7-Tetradecenal, (Z)- 
1.16  Octadecanoic acid 
1.22  Di(1-decynyl)mercury 
4.56  6,11-Undecadiene, 1-acetoxy-3,7-dimethyl- 
1.63  cis-9-Hexadecenoic acid, trimethylsilyl ester 
4.86  2-Hydroxy-(Z)9-pentadecenyl propanoate 


























































































































































































































































































         








     
 
 





   









   
























































































































































































































3.78  E-11-Methyl-12-tetradecen-1-ol acetate 
4.04  11-Dodecyn-1-ol acetate 
4.24  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
2.73  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
2.22  2,3,4-Trimethyl-5-hexen-3-ol 
1.97  9-Methyl-Z,Z-10,12-hexadecadien-1-ol acetat 
1.29  3-Isopropyl-4-methyl-dec-1-en-4-ol 
2.38  Estran-3-one, 17-(acetyloxy)-2-methyl-, (2.alp 
2.42  Cyclopropanecarboxylic acid,pentadecyl ester 
2.28  (R)-(-)-14-Methyl-8-hexadecyn-1-ol 
5.15  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.36  Tetratetracontane 
1.58  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
2.32  13-Docosenamide, (Z)- 
3.29  9-Methyl-10,12-hexadecadien-1-ol acetate 
4.44  11-Dodecyn-1-ol acetate 
1.41  Tetratetracontane 
1.92  2-methylhexacosane 
1.37  Hexadecanal 
1.68  .gamma.-Tocopherol 
1.56  Heneicosane 
1.32  1-Heptacosanol 
1.55  Vitamin E 
1.82  Heptacosyl acetate 
1.70  Hexadecanal 
1.89  Ergost-5-en-3-ol, (3.beta.)- 
1.71  16-Hentriacontanone 
1.85  Stigmasterol 
1.91  Docosyl trifluoroacetate 
2.16  Hexadecanal 
2.06  .gamma.-Sitosterol 
2.38  Hexadecanal 
2.62  17-Pentatriacontene 
2.20  Heptacosyl trifluoroacetate 
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1.94  1,2,3-Propanetriol, 1-acetate 
1.61  1,2,3-Propanetriol, 1-acetate 
1.72  4-Penten-2-one, 3-cyclohexyl- 
0.95  .alfa.-Copaene 
0.99  1H-Cyclopenta[1,3]cyclopropa[1,2]benzene, o 
1.00  Caryophyllene 
1.20  2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1 
0.88  cubedol 
1.63  Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl- 
2.02  Caryophyllene oxide 
1.43  Tetracyclo[6.3.2.0(2,5).0(1,8)]tridecan-9-ol, 4 
1.37  2-Piperidinone, N-[4-bromo-n-butyl]- 
1.31  7-Oxabicyclo[4.1.0]heptane, 1-methyl-4-(2-m 
2.00  3-Buten-2-one, 4-(3-hydroxy-6,6-dimethyl-2- 
1.12  Phytol, acetate 
1.45  2-Pentadecanone, 6,10,14-trimethyl- 
1.21  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.84  Oxirane, hexadecyl- 
0.99  1-Hexacosene 
1.43  Pentadecanoic acid 
1.31  9-Octadecen-1-ol, (Z)- 
1.08  9,17-Octadecadienal, (Z)- 
1.43  1-Heneicosanol 
1.31  2-Ethylnon-1-en-3-ol 
1.13  Phytol 
1.44  11,14-Eicosadienoic acid, methyl ester 


















































































































































































































































































































































   
  
   
         
       
     
                  
  
 
                  
  
   
   


















































































































































































































































































































2.41  7-Tetradecenal, (Z)- 
1.27  Di(1-decynyl)mercury 
2.05  Silane, dimethyl(3-methylbut-3-enyloxy)isobu 
1.54  Phytol, acetate 
1.63  cis-9-Hexadecenoic acid, trimethylsilyl ester 
1.92  cis, 6-Octadecenoic acid, trimethylsilyl ester 
1.66  Decalin-8a-ol-7-one, 4a,8-dimethyl-2-[2-(t-but 
1.31  5-Hexadecanol 
5.40  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
6.25  2-Hydroxy-(Z)9-pentadecenyl propanoate 
5.31  E-11-Methyl-12-tetradecen-1-ol acetate 
5.83  11-Dodecyn-1-ol acetate 
4.29  7-Octen-3-ol, 2,3,6-trimethyl- 
3.42  7-Octen-3-ol, 2,3,6-trimethyl- 
2.08  9-Methyl-Z,Z-10,12-hexadecadien-1-ol acetat 
1.75  3-Isopropyl-4-methyl-dec-1-en-4-ol 
2.08  2-Nonadecanone, O-methyloxime 
2.71  Cyclopropanecarboxylic acid,pentadecyl ester 
3.60  9-Eicosyne 
4.27 Acetic acid, 3-ethylpent-3-yl ester 
4.46  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
2.58  Tetratetracontane 
2.37  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
1.93  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
2.98  13-Docosenamide, (Z)- 
2.60  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
1.80  Hexadecanal 
2.42  9-Methyl-10,12-hexadecadien-1-ol acetate 
3.02  Z-5,17-Octadecadien-1-ol acetate 
1.94  Tetratetracontane 
3.75  Hexadecanal 
1.63  Tetratetracontane 
1.80  Heptacosyl acetate 
1.49  Hexadecanal 
1.48  Tetratetracontane 
1.60  1-Heptacosanol 
2.09  Vitamin E 
1.76  Octacosyl acetate 
1.64  Hexadecanal 
1.90  Ergost-5-en-3-ol, (3.beta.)- 
1.76  16-Hentriacontanone 
1.97  Stigmasterol 
1.92  1-Heptacosanol 
2.51  2-Nonadecanone 
1.96  .gamma.-Sitosterol 
2.32  Octacosyl acetate 
2.99  Hexadecanal 
2.77  Oleic acid, 3-(octadecyloxy)propyl ester 
2.46  Tetracosyl trifluoroacetate 
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: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 09 25.qgt 
Chromatogram PA HEX-Ghana 
TIC 
48,162,295 
3.0 10.0 20.0 25.0 
min 




































































































































































1.79  2-Pentanol, 4-methyl- 
0.98  .alpha.-Cubebene 
0.98  .alfa.-Copaene 
0.97  .beta.-copaene 
1.13  Caryophyllene 
0.94  Humulene 
0.97 Aromandendrene 
1.06  1,6-Cyclodecadiene, 1-methyl-5-methylene-8- 
1.28  .gamma.-Elemene 
1.25  cubedol 
0.98  1,5-Cyclodecadiene, 1,5-dimethyl-8-(1-methyl 
1.73  (-)-Spathulenol 
1.22  Caryophyllene oxide 
1.01  Heptadecanal 
1.17  Tetradecanoic acid 
1.05  Phytol, acetate 
1.09  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.07  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.61  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.87  Pentadecanoic acid 
0.90  Cyclohexane, 2-chloro-4-methyl-1-(1-methyle 
1.14  9-Octadecen-1-ol, (Z)- 
0.94  9,17-Octadecadienal, (Z)- 
1.20  Tetradecyl trifluoroacetate 
1.08  Phytol 
2.81  Cyclopropaneoctanoic acid, 2-[[2-[(2-ethylcyc 







































































































































































































































































































































































     
  
  
   
          
   
             
    
 


































































































































































































































































































































1.61  Octadecanoic acid 
1.43  Di(1-decynyl)mercury 
1.52  3-Methyl-1-dodecyn-3-ol 
1.87  Phytol, acetate 
2.01  cis-9-Hexadecenoic acid, trimethylsilyl ester 
4.43  2-Hydroxy-(Z)9-pentadecenyl propanoate 
4.75  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
4.90  11-Dodecyn-1-ol acetate 
5.04  7-Octen-3-ol, 2,3,6-trimethyl- 
5.05  7-Octen-3-ol, 2,3,6-trimethyl- 
2.02  11-Dodecyn-1-ol acetate 
1.41  3-Isopropyl-4-methyl-dec-1-en-4-ol 
2.44  Estran-3-one, 17-(acetyloxy)-2-methyl-, (2.alp 
3.21  1,2-15,16-Diepoxyhexadecane 
2.40  (R)-(-)-14-Methyl-8-hexadecyn-1-ol 
4.41  1,3-Dioxolane, 2-(1,1-dimethylethyl)-2-methyl 
4.29  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
2.16  2-methyloctacosane 
1.77  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
3.11  13-Docosenamide, (Z)- 
3.58  9-Methyl-10,12-hexadecadien-1-ol acetate 
4.47  Z-5,17-Octadecadien-1-ol acetate 
1.50  Tetratetracontane 
3.61  Oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentam 
1.64  Tetratetracontane 
1.66  Tetracosyl acetate 
1.43  Hexadecanal 
1.71  .gamma.-Tocopherol 
2.30  Tetracosane 
1.48  1-Heptacosanol 
2.76  6,10,14-Trimethyl-pentadecan-2-ol 
2.70  Vitamin E 
1.80  Triacontyl acetate 
2.07  Hexadecanal 
1.99  Ergost-5-en-3-ol, (3.beta.)- 
3.50  16-Hentriacontanone 
2.00  Heneicosyl trifluoroacetate 
2.58  Oxirane, [(hexadecyloxy)methyl]- 
4.46  dl-.alpha.-Tocopherol 
3.30  .gamma.-Sitosterol 
1.89  Stigmastanol 
2.36  Triacontyl acetate 
4.05  dl-.alpha.-Tocopherol 
2.39  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.57  Cholest-4-en-3-one 
2.87  17-Pentatriacontene 
2.19  Docosyl trifluoroacetate 
3.70  Phytol, acetate 
3.44  9,19-Cyclolanostan-3-ol, 24-methylene-, (3.be 
2 / 77 
 
 GC-MS ANALYSIS OF PERSEA 
AMERICANA 
(HEXANE)- South Africa 
















: C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 
: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 07 03.qgt 
Chromatogram PA-HEX-SA 
TIC 
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1.96  cubedol 
1.25  2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4 
2.49  1H-Cycloprop[e]azulen-7-ol, decahydro-1,1,7 
1.92  Caryophyllene oxide 
2.78  1H-Cycloprop[e]azulene, decahydro-1,1,7-tri 
1.35  Eicosanoic acid 
1.77  2-Pentadecanone, 6,10,14-trimethyl- 
2.76  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.51  Pentadecanoic acid 
3.23  6,11-Dimethyl-2,6,10-dodecatrien-1-ol 
2.17  Phytol 
3.15  Z,Z-8,10-Hexadecadien-1-ol 
1.82  Octadecanoic acid 
1.55  Hexadecanamide 
2.96  8-Hexadecanol 
2.47  30-Norlupan-28-oic acid, 3-hydroxy-21-metho 
2.62  Kauran-18-al, 17-(acetyloxy)-, (4.beta.)- 
1.92  Eicosane 
3.24  cis-9-Hexadecenoic acid, trimethylsilyl ester 
3.69  1-Heptanol, 7-(octylthio)- 
1.76  9-Octadecenamide, (Z)- 
3.71  11-Dodecyn-1-ol acetate 
2.38  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
4.06  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
5.96  7-Octen-3-ol, 2,3,6-trimethyl- 
4.09  10-Methyl-E-11-tridece-1-ol acetate 



































































































































































































































































































    
               
































































































































































































3.68  10-Methyl-E-11-tridece-1-ol acetate 
2.02  cis-4,7,10,13,16,19-Docosahexaenoic  acid, ter 
1.63  2-Octylcyclopropene-1-heptanol 
1.09  Tetratetracontane 
2.64  Eicosane 
1.23  Hexadecanal 
5.96  Octadecanoic acid, 9,10-epoxy-, isopropyl este 
1.46  Tetratetracontane 
1.65  Tetratetracontane 
1.41  Oxirane, heptadecyl- 
2.17  .gamma.-Tocopherol 
1.35  Tetratetracontane 
2.32  1-Heptacosanol 
2.30  .alpha.-Tocopheryl acetate 
2.28  Octacosyl acetate 
1.64  Oxirane, heptadecyl- 
2.43  Ergost-5-en-3-ol, (3.beta.)- 
1.78  16-Hentriacontanone 
2.13  Stigmasterol 
3.16  1-Heptacosanol 
2.94  Oxirane, heptadecyl- 
2.51  .gamma.-Sitosterol 
2.54  Hexadecanal 
2.15  Stigmast-4-en-3-one 
3.11  Oxirane, hexadecyl- 
2.87  1-Heptacosanol 
3.15  Stigmastane-3,6-dione, (5.alpha.)- 
4.07  9,19-Cyclolanostan-3-ol, 24-methylene-, (3.be 
4.55  9,19-Cyclolanost-23-ene-3,25-diol,  3-acetate, 
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1.59  2-Propenoic acid, oxiranylmethyl ester 
1.87  2,3-Butanediol, [R-(R*,R*)]- 
2.01  2,3-Butanediol, [R-(R*,R*)]- 
1.35  Ethyl orthoformate 
6.17  (3-Methyl-oxiran-2-yl)-methanol 
1.79  4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6 
2.92  Isosorbide 
1.03  Caryophyllene 
2.14  6-Methyl-6-(5-methylfuran-2-yl)heptan-2-one 
1.16  1,6-Cyclodecadiene, 1-methyl-5-methylene-8- 
3.53  4-epi-cubedol 
1.10  2-Hexanone, 3-methyl-4-methylene- 
3.36  1,3-Benzenediol, 4-propyl- 
1.13  2-Cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5 
1.01  Tetradecanoic acid 
1.51  5-Isopropyl-6-methyl-hepta-3,5-dien-2-ol 
1.13  3,7,11,Trimethyl-8,10- dodecedienylacetate 
1.33  6,11-Undecadiene, 1-acetoxy-3,7-dimethyl- 
1.77  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.68  Phytol, acetate 
1.46  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.30  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.09  Pentadecanoic acid 
1.53  9-Octadecen-1-ol, (Z)- 
1.27  1-Heneicosanol 
1.92  2-Nonadecanone, O-methyloxime 






















































































































































































































































































































   
   
  
     
              
        
    
 










    
  
    
            






















































































































































































































































1.24  Phytol 
2.63  Cyclopropaneoctanoic acid, 2-[[2-[(2-ethylcyc 
1.11  Octadecanoic acid 
1.35  Di(1-decynyl)mercury 
1.26  3-Methyl-1-dodecyn-3-ol 
1.90  3-Methyl-1-dodecyn-3-ol 
1.48  Cyclopropanecarboxylic acid, undec-2-enyl es 
1.38  Cyclopropanecarboxyllic acid, tridec-2-ynyl es 
2.01  (2-Methyl-[1,3]dioxolan-2-yl)-acetic  acid, phe 
7.93  2-Hydroxy-(Z)9-pentadecenyl propanoate 
4.45  Z,Z-4,6-Nonadecadien-1-ol acetate 
4.38  11-Dodecyn-1-ol acetate 
4.07  7-Octen-3-ol, 2,3,6-trimethyl- 
4.27  7-Octen-3-ol, 2,3,6-trimethyl- 
2.30  10-Methyl-E-11-tridece-1-ol acetate 
3.77  2-Nonadecanone, O-methyloxime 
4.00  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.30  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.47  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.48  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
1.94  11-Dodecyn-1-ol acetate 
3.87  9,12-Octadecadienoic acid (Z,Z)-, 2,3-dihydro 
2.76  Octadecanoic acid, 2,3-dihydroxypropyl ester 
1.89  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
2.60  13-Docosenamide, (Z)- 
3.32  9-Methyl-10,12-hexadecadien-1-ol acetate 
2.01  9-Methyl-10,12-hexadecadien-1-ol acetate 
2.59  11-Dodecyn-1-ol acetate 
1.62  2,4-Hexadienedioic acid, 3,4-diethyl-, dimethy 
1.48  .gamma.-Tocopherol 
3.17  Eicosyl pentafluoropropionate 
1.72  Vitamin E 
1.79  Ergost-5-en-3-ol, (3.beta.)- 
2.08  Stigmasterol 
2.45  .gamma.-Sitosterol 
2.21  Stigmastanol 
2.39  dl-.alpha.-Tocopherol 
2.71  17-Pentatriacontene 
3.30  9,19-Cyclolanost-23-ene-3,25-diol,  3-acetate, 
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(ETHANOL)- South Africa 
 
















: C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 
: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 07 03.qgt 
Chromatogram PA-EtOH(SA) 
TIC 
3.0 10.0 20.0 25.0 
min 




































































































































































0.96  Formamide, N-methoxy- 
5.66  Benzene, chloro- 
1.04  Phytol, acetate 
1.15  2-Pentadecanone, 6,10,14-trimethyl- 
1.00  1-Hexacosene 
1.24  Pentadecanoic acid 
1.69  Phytol 
1.26  9,12-Octadecadienoic acid (Z,Z)- 
1.80  cis,cis,cis-7,10,13-Hexadecatrienal 
1.20  Octadecanoic acid 
1.32  Hexadecanamide 
1.97  Silane, dimethyl(2-decyloxy)propoxy- 
1.62  cis-9-Hexadecenoic acid, trimethylsilyl ester 
1.31  9-Octadecenamide, (Z)- 
1.66  11-Dodecyn-1-ol acetate 
1.61  Octadecanamide 
2.73  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
4.43  2,3,4-Trimethyl-5-hexen-3-ol 
5.47  7-Octen-3-ol, 2,3,6-trimethyl- 
3.04  Geranyl acetate, 2,3-epoxy- 
2.93  10-Methyl-E-11-tridece-1-ol acetate 
2.03  10-Methyl-E-11-tridece-1-ol acetate 
2.39  10-Methyl-E-11-tridece-1-ol acetate 
1.00  Heneicosane 
1.32  Tetratetracontane 
2.38  n-Tetracosanol-1 


































































































































    
    
  
    
       




































2.45  3.alpha.,7.beta.-Dihydroxy-5.beta.,6.beta.-epo 
1.73  16-Hentriacontanone 
2.23  Stigmasterol 
2.46  .gamma.-Sitosterol 
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GC-MS ANALYSIS OF PERSEA 
AMERICANA 
(ETHYL ACETATE)- Ghana 
 
















: C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 
: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 09 25.qgt 
Chromatogram PAEtoAc-Ghana 
TIC 
3.0 10.0 20.0 25.0 
min 




































































































































































1.12  Benzene, 1,3-dimethyl- 
0.90  Pentanoic acid, ethyl ester 
0.84  Bicyclo[3.1.0]hexane, 4-methylene-1-(1-meth 
1.11  1-Heptanol, 2-propyl- 
1.02  .alpha.-Cubebene 
0.98  .alfa.-Copaene 
1.02  .beta.-copaene 
1.16  Caryophyllene 
1.04  Humulene 
0.99 Aromandendrene 
1.02  1,6-Cyclodecadiene, 1-methyl-5-methylene-8- 
1.05  .gamma.-Elemene 
1.12  cubedol 
1.01  1,5-Cyclodecadiene, 1,5-dimethyl-8-(1-methyl 
1.65  (-)-Spathulenol 
0.97  Caryophyllene oxide 
1.08  Heptadecanal 
1.08  Tetradecanoic acid 
1.07  3,7,11,Trimethyl-8,10- dodecedienylacetate 
1.05  Cyclohexane, 2-chloro-4-methyl-1-(1-methyle 
1.24  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.16  Phytol, acetate 
1.61  2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R* 
1.45  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.27  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.99  Pentadecanoic acid 




















































































































































































































































































































































   
 
   
    
  
    
  
                        
                      




    
       
   
 
  
   
       


















































































































































































































































































































0.94  Cyclohexane, 2-chloro-4-methyl-1-(1-methyle 
0.85  9-Octadecen-1-ol, (Z)- 
0.93  9,17-Octadecadienal, (Z)- 
1.15  n-Heptadecanol-1 
1.10  Phytol 
2.71  cis,cis,cis-7,10,13-Hexadecatrienal 
1.42  Octadecanoic acid 
1.39  Di(1-decynyl)mercury 
1.20  3-Methyl-1-dodecyn-3-ol 
1.69  Phytol, acetate 
2.17  2-Isopropenyl-5-methylhex-4-enal 
1.20  3-Methyl-1-dodecyn-3-ol 
7.72  2-Hydroxy-(Z)9-pentadecenyl propanoate 
4.84  10,11-Epoxy-n-undecan-1-ol 
3.88  11-Dodecyn-1-ol acetate 
5.66  7-Octen-3-ol, 2,3,6-trimethyl- 
4.45  7-Octen-3-ol, 2,3,6-trimethyl- 
1.83  10-Methyl-E-11-tridece-1-ol acetate 
2.91  Estran-3-one, 17-(acetyloxy)-2-methyl-, (2.alp 
3.36  Cyclopropanecarboxylic acid, heptadecyl ester 
2.34  9-Eicosyne 
3.99  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.55  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
3.39  Tetratetracontane 
1.81  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
2.95  13-Docosenamide, (Z)- 
2.36  9-Methyl-10,12-hexadecadien-1-ol acetate 
2.75  9-Methyl-10,12-hexadecadien-1-ol acetate 
1.28  Tetratetracontane 
1.69  Tetratetracontane 
1.78  Tetracosyl acetate 
1.52  Hexadecanal 
1.66  .gamma.-Tocopherol 
1.75  Tetratetracontane 
1.63  1-Heptacosanol 
2.36  Vitamin E 
1.80  Octacosyl acetate 
2.70  Hexadecanal 
2.03  Ergost-5-en-3-ol, (3.beta.)- 
2.30  16-Hentriacontanone 
1.80  Stigmasterol 
2.02  Docosyl trifluoroacetate 
5.14  .alpha.-Tocopherol-.beta.-D-mannoside 
2.97  .gamma.-Sitosterol 
1.96  Stigmastanol 
2.70  dl-.alpha.-Tocopherol 
3.30  Oleic acid, 3-(octadecyloxy)propyl ester 
2.38  Docosyl trifluoroacetate 
3.39  9,19-Cyclolanost-23-ene-3,25-diol,  3-acetate, 
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GC-MS ANALYSIS OF PERSEA 
AMERICANA 
(ETHYL ACETATE)- South Africa 
 
















: C:\Shimadzu GCMS\Raw Data 2017-8\UKZN - M Nlooto\M Nlooto - split.qgm 
: C:\GCMSsolution\System\Tune1\Normal Conc - 2018 09 25.qgt 
Chromatogram PAEtoAc-SA 
TIC 
3.0 10.0 20.0 25.0 
min 




































































































































































2.55  1,2,3-Propanetriol, 1-acetate 
1.25  1,2,3-Propanetriol, 1-acetate 
0.98  Caryophyllene 
0.96  1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (E 
1.21  Phytol, acetate 
1.19  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
1.45  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
2.14  Pentadecanoic acid 
1.24  9-Octadecen-1-ol, (Z)- 
1.19  Phytol 
2.72  7-Tetradecenal, (Z)- 
1.73  Octadecanoic acid 
1.22  Di(1-decynyl)mercury 
1.82  3-Methyl-1-dodecyn-3-ol 
1.03  Phytol, acetate 
1.39  cis-9-Hexadecenoic acid, trimethylsilyl ester 
6.81  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
8.49  2-Hydroxy-(Z)9-pentadecenyl propanoate 
5.26  2-Hydroxy-(Z)9-pentadecenyl propanoate 
3.90  (2-Methyl-[1,3]dioxolan-2-yl)-acetic  acid, phe 
2.93  (R)-(-)-14-Methyl-8-hexadecyn-1-ol 
4.32  7-Octen-3-ol, 2,3,6-trimethyl- 
3.37  7-Octen-3-ol, 2,3,6-trimethyl- 
2.48  10-Methyl-E-11-tridece-1-ol acetate 
2.50  2-Nonadecanone, O-methyloxime 
3.14  Cyclopropanecarboxylic acid,pentadecyl ester 











































































































































































































































































































   
  
  
    
             
         
              
    
  
  
   
 
   
   
      
























































































































































































































2.91  E-11-Methyl-12-tetradecen-1-ol acetate 
4.43 Acetic acid, 3-ethylpent-3-yl ester 
4.08  Z-(13,14-Epoxy)tetradec-11-en-1-ol  acetate 
1.48  Tetratetracontane 
3.74  11-Dodecyn-1-ol acetate 
2.11  3-Methyl-2-(2-methylene-cyclohexyl)-butan-2 
2.63  Ethanol, 2-(9,12-octadecadienyloxy)-, (Z,Z)- 
2.95  Z,Z-5,16-Octadecadien-1-ol acetate 
1.45  Squalene 
3.15  Tetracosanal 
2.15  9-Methyl-10,12-hexadecadien-1-ol acetate 
2.61  Z-5,17-Octadecadien-1-ol acetate 
1.80  Tetratetracontane 
1.54  Tetratetracontane 
1.65  Heptacosyl acetate 
1.69  Hexadecanal 
1.40  .gamma.-Tocopherol 
1.65  Tetratetracontane 
1.64  1-Heptacosanol 
1.68  Vitamin E 
1.86  Octacosyl acetate 
1.83  Hexadecanal 
1.98  Ergost-5-en-3-ol, (3.beta.)- 
7.64  Stigmasterol 
1.97  1-Heptacosanol 
2.91  .gamma.-Sitosterol 
2.52  Octacosyl acetate 
2.44  4,22-Stigmastadiene-3-one 
3.38  dl-.alpha.-Tocopherol 
3.37  Oleic acid, 3-(octadecyloxy)propyl ester 
2.22  Tetracosyl pentafluoropropionate 
2.81  Phytol, acetate 
3.24  13,15-Octacosadiyne 
2.92  9,19-Cyclolanostan-3-ol, 24-methylene-, (3.be 
2 / 62 
 
